Global Transcranial Magnetic Stimulator Market By Components, By Type, By Application, By Age Group, By Hz, By End Users & By Region & Segmental Forecast, 2023 – 2031

  • Industry: Healthcare
  • Report ID: TNR-110-915
  • Number of Pages: 420
  • Table/Charts : Yes
  • November, 2023
  • Base Year : 2024
  • No. of Companies : 8+
  • No. of Countries : 29
  • Views : 10187
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

In Terms of Revenue, Global Transcranial Magnetic Stimulator Market Reached Valuation of US$ 1.43 Bn in 2022, Projected to Achieve CAGR of 9.05% During 2023 – 2031 Global Transcranial Magnetic Stimulator Market Overview

Transcranial magnetic stimulator (TMS) market has been experiencing substantial growth in recent years due to advancements in medical technology, rising awareness about mental health, and increasing prevalence of neurological disorders. Transcranial Magnetic Stimulation (TMS) is a non-invasive medical procedure that uses electromagnetic fields to stimulate nerve cells in the brain, offering potential therapeutic benefits for various neuropsychiatric conditions. Transcranial magnetic stimulation (TMS) is gaining prominence as a promising therapeutic intervention for conditions such as depression, anxiety, schizophrenia, and even certain neurological disorders like migraines. The global transcranial magnetic stimulator market has witnessed substantial growth over the past decade, driven by increasing research activities, growing clinical evidence supporting its efficacy, and rising demand for non-invasive treatments.

Global Transcranial Magnetic Stimulator Market Revenue & Forecast, (US$ Million), 2015 – 2031of Form

The outbreak of the COVID-19 pandemic in late 2019 had profound implications for economies, industries, and healthcare systems worldwide. The transcranial magnetic stimulator (TMS) market was no exception, experiencing both challenges and opportunities as a result of the pandemic.  The transcranial magnetic stimulator market relies on a complex global supply chain for components and materials. The pandemic’s disruption to international trade and manufacturing processes led to delays and shortages in the production and distribution of TMS devices.

With patients avoiding medical facilities due to infection concerns, there was a growing interest in home-based TMS treatments. This trend prompted TMS manufacturers to consider portable and user-friendly devices for personal use. Furthermore, the pandemic’s impact on mental health brought increased attention to conditions like depression, anxiety, and PTSD. This spotlight on mental health encouraged discussions about alternative treatments like TMS.

Report Coverage and Deliverables: Key Drivers: Several factors are fueling the growth of the transcranial magnetic stimulator market:

  • Rising Prevalence of Mental Health Disorders: The increasing prevalence of mental health disorders, such as depression and anxiety, is a significant driver for the transcranial magnetic stimulator TMS offers an alternative treatment option for patients who are unresponsive to traditional therapies.
  • Advancements in Technology: Technological advancements in TMS devices, including improved precision, customizable treatment protocols, and enhanced patient comfort, have expanded the market’s reach and acceptance.
  • Growing Research and Clinical Trials: Ongoing research and clinical trials demonstrating the effectiveness of TMS for various neurological and psychiatric disorders are boosting its adoption by healthcare providers and patients.
  • Non-Invasiveness and Safety: TMS is a non-invasive procedure with minimal side effects compared to other treatment options, making it an attractive choice for both patients and clinicians.
  • Increasing Investment in Mental Healthcare: Government bodies and private organizations are recognizing the importance of mental health and investing in advanced treatment options, which is positively impacting the transcranial magnetic stimulator

Evolving Landscape of the Adults’ Transcranial Magnetic Stimulator Market

Transcranial magnetic stimulator market has witnessed distinct dynamics between the segments of children and adults. The primary applications of Children’s TMS include addressing developmental disorders like attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders. Research and clinical trials are ongoing to explore its efficacy and safety for paediatric use. In the realm of brain health treatments, the Adult transcranial magnetic stimulator market has experienced remarkable growth, with a surge in adoption and an evolving landscape of statistics and trends.

As a non-invasive and versatile therapeutic approach, TMS has gained traction for its potential to address various neurological and psychiatric conditions in adults. Initially focused on depression, the range of indications for Adult TMS has expanded. It now encompasses mood disorders, anxiety disorders, neurodegenerative conditions (such as Parkinson’s disease and Alzheimer’s), chronic pain management, and cognitive enhancement. Additionally, the concept of home-based transcranial magnetic stimulator market is gaining traction. This trend aims to provide patients with the convenience of receiving treatments in their own environment while adhering to prescribed protocols under remote medical supervision. The adults transcranial magnetic stimulator market segment accounted for more than 58.6% in 2022.

Thriving Transcranial Magnetic Stimulator Market in North America: A Landscape Overview

North American transcranial magnetic stimulator market boasts a substantial market share of ~40.8%, reflecting the region’s robust demand for innovative brain health solutions. The market’s value has reached significant figures, driven by factors such as clinical endorsements and patient awareness.  North America is a hotspot for TMS research and innovation. Leading universities, medical centers, and private companies collaborate to advance the understanding of TMS mechanisms, refine protocols, and explore novel applications.

Regulatory agencies in North America, namely the U.S. Food and Drug Administration (FDA) & Health Canada, play a pivotal role in ensuring safety and efficacy in medical devices like TMS. Their approvals and oversight contribute to the legitimacy of TMS treatments. The North American transcranial magnetic stimulator market benefits from multidisciplinary collaborations between neuroscientists, clinicians, engineers, and data scientists. This convergence of expertise accelerates the development of innovative TMS technologies. Additionally, North America leads in the development of advanced TMS devices, incorporating features such as real-time monitoring, precision targeting, and improved patient comfort. These technological advancements drive patient satisfaction and outcomes.

Competitive Landscape

A few of the key players operating in the global transcranial magnetic stimulator market are:

  • BrainsWay
  • eNeura Inc.
  • Magnus Medical
  • Magstim
  • MagVenture, Inc.
  • Neuronetics
  • Neurosoft
  • Nexstim, Inc.
  • Sebers Medical
  • Other Market Participants

Report Summary of Global Transcranial Magnetic Stimulator Market

Report Specifications Details
Market Revenue in 2022 US$ 1.43 Billion
Market Size Forecast by 2031 US$ 2.78 Billion
Growth Rate (CAGR) 9.05 %
Historic Data 2015 – 2021
Base Year for Estimation 2022
Forecast Period 2023 – 2031
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Components, By Type, By Application, By Age Group, By Hz, By End Users
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players BrainsWay, eNeura Inc., Magnus Medical, Magstim, MagVenture, Inc., Neuronetics, Neurosoft, Nexstim, Inc., Sebers Medical, Other Industry Participants
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free): – +81 663-386-8111

South Korea (Toll-Free): – +82-808- 703-126

Saudi Arabia (Toll-Free): – +966 800 850 1643

United States: +1 302-232-5106

United Kingdom: +447537105080

E-mail:  askanexpert@thenicheresearch.com

 

Global Transcranial Magnetic Stimulator MarketBy Components

  • Products
    • TMS Coils
    • Stimulators
  • Software
  • Services
    • Software Update
    • Technical Support
    • Others
  • Accessories
    • Trolley
    • Control Cable
    • HV Cable
    • Others

By Type

  • Single-pulse
  • Paired Pulse
  • Repetitive TMS (rTMS)
  • Deep Transcranial Magnetic Stimulation (dTMS)

By Application

  • Psychiatric Treatments
    • Major Depressive Disorder
    • Obsessive Compulsive Disorder
    • Bipolar Disorder
    • Post-Traumatic Stress Disorder
    • Schizophrenia
    • Smoking Cessation
  • Neurological Treatments
    • Alzheimer’s Disease
    • Autism
    • Chronic Pain
    • Multiple Sclerosis
    • Parkinson’s Disease
    • Post Stroke Rehabilitation
    • Others

By Age Group

  • Pediatric
  • Adults
  • Geriatric

By Hz

  • Up to 10
  • Up to 50
  • Up to 100

By End Users

  • Hospitals and Clinics
    • Small and Start-up Clinic
    • Large and Multi-site Practices
  • Research Centers
  • Deep TMS Treatment Centers
  • Others

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

 

Table of Contents

.

1.Market Scope
1.1.Market Segmentation
1.2.Years Considered
1.2.1.Historic Years: 2015 – 2021
1.2.2.Base Year: 2022
1.2.3.Forecast Years: 2023 – 2031
2.Key Target Audiences
3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire
3.1.2.Global Percentage Breakdown
3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)
3.2.Secondary Research
3.2.1.Paid Databases
3.2.2.Secondary Sources
3.3.Market Size Estimates
3.3.1.Top-Down Approach
3.3.2.Bottom-Up Approach
3.4.Data Triangulation Methodology
3.5.Research Assumptions
4.Recommendations and Insights from TNR’s Perspective**
5.Holistic Overview of Transcranial Magnetic Stimulator Market
6.Market Synopsis: Transcranial Magnetic Stimulator Market
7.Transcranial Magnetic Stimulator Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition
7.1.2.Industry Development
7.2.Market Dynamics
7.2.1.Drivers
7.2.2.Restraints
7.2.3.Opportunities
7.2.4.Challenges
7.3.Trends in Transcranial Magnetic Stimulator Market
7.4.Market Determinants Radar Chart
7.5.Macro-Economic and Micro-Economic Indicators: Transcranial Magnetic Stimulator Market
7.6.Porter’s Five Force Analysis
7.7.Impact of Covid-19 on Transcranial Magnetic Stimulator Market
7.8.PESTEL Analysis
8.Global Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
8.1.Overview
8.1.1.Global Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
8.2.Global Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
8.2.1.Products (Definition, Market Estimation and Penetration, 2015 – 2022, Market Estimation (2015 – 2022), Market Forecast (2023 – 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on TMS Coils, Stimulators)
8.2.1.1.TMS Coils
8.2.1.2.Stimulators
8.2.2.Software
8.2.2.1.Definition
8.2.2.2.Market Estimation and Penetration, 2015 – 2022
8.2.2.3.Market Forecast, 2023 – 2031
8.2.2.4.Compound Annual Growth Rate (CAGR)
8.2.2.5.Regional Bifurcation
8.2.2.5.1.North America
8.2.2.5.1.1.Market Estimation, 2015 – 2022
8.2.2.5.1.2.Market Forecast, 2023 – 2031
8.2.2.5.2.Europe
8.2.2.5.2.1.Market Estimation, 2015 – 2022
8.2.2.5.2.2.Market Forecast, 2023 – 2031
8.2.2.5.3.Asia Pacific
8.2.2.5.3.1.Market Estimation, 2015 – 2022
8.2.2.5.3.2.Market Forecast, 2023 – 2031
8.2.2.5.4.Middle East and Africa
8.2.2.5.4.1.Market Estimation, 2015 – 2022
8.2.2.5.4.2.Market Forecast, 2023 – 2031
8.2.2.5.5.Latin America
8.2.2.5.5.1.Market Estimation, 2015 – 2022
8.2.2.5.5.2.Market Forecast, 2023 – 2031
8.2.3.Services (Definition, Market Estimation and Penetration, 2015 – 2022, Market Estimation (2015 – 2022), Market Forecast (2023 – 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Software Update, Technical Support, Others)
8.2.3.1.Software Update
8.2.3.2.Technical Support
8.2.3.3.Others
8.2.4.Accessories (Definition, Market Estimation and Penetration, 2015 – 2022, Market Estimation (2015 – 2022), Market Forecast (2023 – 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Trolley, Control Cable, HV Cable, Others)
8.2.4.1.Trolley
8.2.4.2.Control Cable
8.2.4.3.HV Cable
8.2.4.4.Others
8.3.Key Segment for Channeling Investments
8.3.1.By Components
9.Global Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
9.1.Overview
9.2.Global Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
9.2.1.Single-pulse
9.2.1.1.Definition
9.2.1.2.Market Estimation and Penetration, 2015 – 2022
9.2.1.3.Market Forecast, 2023 – 2031
9.2.1.4.Compound Annual Growth Rate (CAGR)
9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2015 – 2022
9.2.1.5.1.2.Market Forecast, 2023 – 2031
9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2015 – 2022
9.2.1.5.2.2.Market Forecast, 2023 – 2031
9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2015 – 2022
9.2.1.5.3.2.Market Forecast, 2023 – 2031
9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2015 – 2022
9.2.1.5.4.2.Market Forecast, 2023 – 2031
9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2015 – 2022
9.2.1.5.5.2.Market Forecast, 2023 – 2031
9.2.2.Paired Pulse
9.2.2.1.Definition
9.2.2.2.Market Estimation and Penetration, 2015 – 2022
9.2.2.3.Market Forecast, 2023 – 2031
9.2.2.4.Compound Annual Growth Rate (CAGR)
9.2.2.5.Regional Bifurcation
9.2.2.5.1.North America
9.2.2.5.1.1.Market Estimation, 2015 – 2022
9.2.2.5.1.2.Market Forecast, 2023 – 2031
9.2.2.5.2.Europe
9.2.2.5.2.1.Market Estimation, 2015 – 2022
9.2.2.5.2.2.Market Forecast, 2023 – 2031
9.2.2.5.3.Asia Pacific
9.2.2.5.3.1.Market Estimation, 2015 – 2022
9.2.2.5.3.2.Market Forecast, 2023 – 2031
9.2.2.5.4.Middle East and Africa
9.2.2.5.4.1.Market Estimation, 2015 – 2022
9.2.2.5.4.2.Market Forecast, 2023 – 2031
9.2.2.5.5.Latin America
9.2.2.5.5.1.Market Estimation, 2015 – 2022
9.2.2.5.5.2.Market Forecast, 2023 – 2031
9.2.3.Repetitive TMS (rTMS)
9.2.3.1.Definition
9.2.3.2.Market Estimation and Penetration, 2015 – 2022
9.2.3.3.Market Forecast, 2023 – 2031
9.2.3.4.Compound Annual Growth Rate (CAGR)
9.2.3.5.Regional Bifurcation
9.2.3.5.1.North America
9.2.3.5.1.1.Market Estimation, 2015 – 2022
9.2.3.5.1.2.Market Forecast, 2023 – 2031
9.2.3.5.2.Europe
9.2.3.5.2.1.Market Estimation, 2015 – 2022
9.2.3.5.2.2.Market Forecast, 2023 – 2031
9.2.3.5.3.Asia Pacific
9.2.3.5.3.1.Market Estimation, 2015 – 2022
9.2.3.5.3.2.Market Forecast, 2023 – 2031
9.2.3.5.4.Middle East and Africa
9.2.3.5.4.1.Market Estimation, 2015 – 2022
9.2.3.5.4.2.Market Forecast, 2023 – 2031
9.2.3.5.5.Latin America
9.2.3.5.5.1.Market Estimation, 2015 – 2022
9.2.3.5.5.2.Market Forecast, 2023 – 2031
9.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
9.2.4.1.Definition
9.2.4.2.Market Estimation and Penetration, 2015 – 2022
9.2.4.3.Market Forecast, 2023 – 2031
9.2.4.4.Compound Annual Growth Rate (CAGR)
9.2.4.5.Regional Bifurcation
9.2.4.5.1.North America
9.2.4.5.1.1.Market Estimation, 2015 – 2022
9.2.4.5.1.2.Market Forecast, 2023 – 2031
9.2.4.5.2.Europe
9.2.4.5.2.1.Market Estimation, 2015 – 2022
9.2.4.5.2.2.Market Forecast, 2023 – 2031
9.2.4.5.3.Asia Pacific
9.2.4.5.3.1.Market Estimation, 2015 – 2022
9.2.4.5.3.2.Market Forecast, 2023 – 2031
9.2.4.5.4.Middle East and Africa
9.2.4.5.4.1.Market Estimation, 2015 – 2022
9.2.4.5.4.2.Market Forecast, 2023 – 2031
9.2.4.5.5.Latin America
9.2.4.5.5.1.Market Estimation, 2015 – 2022
9.2.4.5.5.2.Market Forecast, 2023 – 2031
9.3.Key Segment for Channeling Investments
9.3.1.By Type
10.Global Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
10.1.Overview
10.2.Global Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1.Psychiatric Treatments (Definition, Market Estimation and Penetration, 2015 – 2022, Market Estimation (2015 – 2022), Market Forecast (2023 – 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Major Depressive Disorder, Obsessive Compulsive Disorder, Bipolar Disorder, Post-Traumatic Stress Disorder, Schizophrenia, Smoking Cessation)
10.2.1.1.Major Depressive Disorder
10.2.1.2.Obsessive Compulsive Disorder
10.2.1.3.Bipolar Disorder
10.2.1.4.Post-Traumatic Stress Disorder
10.2.1.5.Schizophrenia
10.2.1.6.Smoking Cessation
10.2.2.Neurological Treatments (Definition, Market Estimation and Penetration, 2015 – 2022, Market Estimation (2015 – 2022), Market Forecast (2023 – 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Alzheimer’s Disease, Autism, Chronic Pain, Multiple Sclerosis, Parkinson’s Disease, Post Stroke Rehabilitation, Others)
10.2.2.1.Alzheimer’s Disease
10.2.2.2.Autism
10.2.2.3.Chronic Pain
10.2.2.4.Multiple Sclerosis
10.2.2.5.Parkinson’s Disease
10.2.2.6.Post Stroke Rehabilitation
10.2.2.7.Others
10.3.Key Segment for Channeling Investments
10.3.1.By Application
11.Global Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
11.1.Overview
11.2.Global Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
11.2.1.Pediatric
11.2.1.1.Definition
11.2.1.2.Market Estimation and Penetration, 2015 – 2022
11.2.1.3.Market Forecast, 2023 – 2031
11.2.1.4.Compound Annual Growth Rate (CAGR)
11.2.1.5.Regional Bifurcation
11.2.1.5.1.North America
11.2.1.5.1.1.Market Estimation, 2015 – 2022
11.2.1.5.1.2.Market Forecast, 2023 – 2031
11.2.1.5.2.Europe
11.2.1.5.2.1.Market Estimation, 2015 – 2022
11.2.1.5.2.2.Market Forecast, 2023 – 2031
11.2.1.5.3.Asia Pacific
11.2.1.5.3.1.Market Estimation, 2015 – 2022
11.2.1.5.3.2.Market Forecast, 2023 – 2031
11.2.1.5.4.Middle East and Africa
11.2.1.5.4.1.Market Estimation, 2015 – 2022
11.2.1.5.4.2.Market Forecast, 2023 – 2031
11.2.1.5.5.Latin America
11.2.1.5.5.1.Market Estimation, 2015 – 2022
11.2.1.5.5.2.Market Forecast, 2023 – 2031
11.2.2.Adults
11.2.2.1.Definition
11.2.2.2.Market Estimation and Penetration, 2015 – 2022
11.2.2.3.Market Forecast, 2023 – 2031
11.2.2.4.Compound Annual Growth Rate (CAGR)
11.2.2.5.Regional Bifurcation
11.2.2.5.1.North America
11.2.2.5.1.1.Market Estimation, 2015 – 2022
11.2.2.5.1.2.Market Forecast, 2023 – 2031
11.2.2.5.2.Europe
11.2.2.5.2.1.Market Estimation, 2015 – 2022
11.2.2.5.2.2.Market Forecast, 2023 – 2031
11.2.2.5.3.Asia Pacific
11.2.2.5.3.1.Market Estimation, 2015 – 2022
11.2.2.5.3.2.Market Forecast, 2023 – 2031
11.2.2.5.4.Middle East and Africa
11.2.2.5.4.1.Market Estimation, 2015 – 2022
11.2.2.5.4.2.Market Forecast, 2023 – 2031
11.2.2.5.5.Latin America
11.2.2.5.5.1.Market Estimation, 2015 – 2022
11.2.2.5.5.2.Market Forecast, 2023 – 2031
11.2.3.Geriatric
11.2.3.1.Definition
11.2.3.2.Market Estimation and Penetration, 2015 – 2022
11.2.3.3.Market Forecast, 2023 – 2031
11.2.3.4.Compound Annual Growth Rate (CAGR)
11.2.3.5.Regional Bifurcation
11.2.3.5.1.North America
11.2.3.5.1.1.Market Estimation, 2015 – 2022
11.2.3.5.1.2.Market Forecast, 2023 – 2031
11.2.3.5.2.Europe
11.2.3.5.2.1.Market Estimation, 2015 – 2022
11.2.3.5.2.2.Market Forecast, 2023 – 2031
11.2.3.5.3.Asia Pacific
11.2.3.5.3.1.Market Estimation, 2015 – 2022
11.2.3.5.3.2.Market Forecast, 2023 – 2031
11.2.3.5.4.Middle East and Africa
11.2.3.5.4.1.Market Estimation, 2015 – 2022
11.2.3.5.4.2.Market Forecast, 2023 – 2031
11.2.3.5.5.Latin America
11.2.3.5.5.1.Market Estimation, 2015 – 2022
11.2.3.5.5.2.Market Forecast, 2023 – 2031
11.3.Key Segment for Channeling Investments
11.3.1.By Age Group
12.Global Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
12.1.Overview
12.2.Global Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
12.2.1.Up to 10
12.2.1.1.Definition
12.2.1.2.Market Estimation and Penetration, 2015 – 2022
12.2.1.3.Market Forecast, 2023 – 2031
12.2.1.4.Compound Annual Growth Rate (CAGR)
12.2.1.5.Regional Bifurcation
12.2.1.5.1.North America
12.2.1.5.1.1.Market Estimation, 2015 – 2022
12.2.1.5.1.2.Market Forecast, 2023 – 2031
12.2.1.5.2.Europe
12.2.1.5.2.1.Market Estimation, 2015 – 2022
12.2.1.5.2.2.Market Forecast, 2023 – 2031
12.2.1.5.3.Asia Pacific
12.2.1.5.3.1.Market Estimation, 2015 – 2022
12.2.1.5.3.2.Market Forecast, 2023 – 2031
12.2.1.5.4.Middle East and Africa
12.2.1.5.4.1.Market Estimation, 2015 – 2022
12.2.1.5.4.2.Market Forecast, 2023 – 2031
12.2.1.5.5.Latin America
12.2.1.5.5.1.Market Estimation, 2015 – 2022
12.2.1.5.5.2.Market Forecast, 2023 – 2031
12.2.2.Up to 50
12.2.2.1.Definition
12.2.2.2.Market Estimation and Penetration, 2015 – 2022
12.2.2.3.Market Forecast, 2023 – 2031
12.2.2.4.Compound Annual Growth Rate (CAGR)
12.2.2.5.Regional Bifurcation
12.2.2.5.1.North America
12.2.2.5.1.1.Market Estimation, 2015 – 2022
12.2.2.5.1.2.Market Forecast, 2023 – 2031
12.2.2.5.2.Europe
12.2.2.5.2.1.Market Estimation, 2015 – 2022
12.2.2.5.2.2.Market Forecast, 2023 – 2031
12.2.2.5.3.Asia Pacific
12.2.2.5.3.1.Market Estimation, 2015 – 2022
12.2.2.5.3.2.Market Forecast, 2023 – 2031
12.2.2.5.4.Middle East and Africa
12.2.2.5.4.1.Market Estimation, 2015 – 2022
12.2.2.5.4.2.Market Forecast, 2023 – 2031
12.2.2.5.5.Latin America
12.2.2.5.5.1.Market Estimation, 2015 – 2022
12.2.2.5.5.2.Market Forecast, 2023 – 2031
12.2.3.Up to 100
12.2.3.1.Definition
12.2.3.2.Market Estimation and Penetration, 2015 – 2022
12.2.3.3.Market Forecast, 2023 – 2031
12.2.3.4.Compound Annual Growth Rate (CAGR)
12.2.3.5.Regional Bifurcation
12.2.3.5.1.North America
12.2.3.5.1.1.Market Estimation, 2015 – 2022
12.2.3.5.1.2.Market Forecast, 2023 – 2031
12.2.3.5.2.Europe
12.2.3.5.2.1.Market Estimation, 2015 – 2022
12.2.3.5.2.2.Market Forecast, 2023 – 2031
12.2.3.5.3.Asia Pacific
12.2.3.5.3.1.Market Estimation, 2015 – 2022
12.2.3.5.3.2.Market Forecast, 2023 – 2031
12.2.3.5.4.Middle East and Africa
12.2.3.5.4.1.Market Estimation, 2015 – 2022
12.2.3.5.4.2.Market Forecast, 2023 – 2031
12.2.3.5.5.Latin America
12.2.3.5.5.1.Market Estimation, 2015 – 2022
12.2.3.5.5.2.Market Forecast, 2023 – 2031
12.3.Key Segment for Channeling Investments
12.3.1.By Hz
13.Global Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
13.1.Overview
13.2.Global Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
13.2.1.Hospitals and Clinics (Definition, Market Estimation and Penetration, 2015 – 2022, Market Estimation (2015 – 2022), Market Forecast (2023 – 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Small and Start-up Clinic, Large and Multi-site Practices)
13.2.1.1.Small and Start-up Clinic
13.2.1.2.Large and Multi-site Practices
13.2.2.Research Centers
13.2.2.1.Definition
13.2.2.2.Market Estimation and Penetration, 2015 – 2022
13.2.2.3.Market Forecast, 2023 – 2031
13.2.2.4.Compound Annual Growth Rate (CAGR)
13.2.2.5.Regional Bifurcation
13.2.2.5.1.North America
13.2.2.5.1.1.Market Estimation, 2015 – 2022
13.2.2.5.1.2.Market Forecast, 2023 – 2031
13.2.2.5.2.Europe
13.2.2.5.2.1.Market Estimation, 2015 – 2022
13.2.2.5.2.2.Market Forecast, 2023 – 2031
13.2.2.5.3.Asia Pacific
13.2.2.5.3.1.Market Estimation, 2015 – 2022
13.2.2.5.3.2.Market Forecast, 2023 – 2031
13.2.2.5.4.Middle East and Africa
13.2.2.5.4.1.Market Estimation, 2015 – 2022
13.2.2.5.4.2.Market Forecast, 2023 – 2031
13.2.2.5.5.Latin America
13.2.2.5.5.1.Market Estimation, 2015 – 2022
13.2.2.5.5.2.Market Forecast, 2023 – 2031
13.2.3.Deep TMS Treatment Centers
13.2.3.1.Definition
13.2.3.2.Market Estimation and Penetration, 2015 – 2022
13.2.3.3.Market Forecast, 2023 – 2031
13.2.3.4.Compound Annual Growth Rate (CAGR)
13.2.3.5.Regional Bifurcation
13.2.3.5.1.North America
13.2.3.5.1.1.Market Estimation, 2015 – 2022
13.2.3.5.1.2.Market Forecast, 2023 – 2031
13.2.3.5.2.Europe
13.2.3.5.2.1.Market Estimation, 2015 – 2022
13.2.3.5.2.2.Market Forecast, 2023 – 2031
13.2.3.5.3.Asia Pacific
13.2.3.5.3.1.Market Estimation, 2015 – 2022
13.2.3.5.3.2.Market Forecast, 2023 – 2031
13.2.3.5.4.Middle East and Africa
13.2.3.5.4.1.Market Estimation, 2015 – 2022
13.2.3.5.4.2.Market Forecast, 2023 – 2031
13.2.3.5.5.Latin America
13.2.3.5.5.1.Market Estimation, 2015 – 2022
13.2.3.5.5.2.Market Forecast, 2023 – 2031
13.2.4.Others
13.2.4.1.Definition
13.2.4.2.Market Estimation and Penetration, 2015 – 2022
13.2.4.3.Market Forecast, 2023 – 2031
13.2.4.4.Compound Annual Growth Rate (CAGR)
13.2.4.5.Regional Bifurcation
13.2.4.5.1.North America
13.2.4.5.1.1.Market Estimation, 2015 – 2022
13.2.4.5.1.2.Market Forecast, 2023 – 2031
13.2.4.5.2.Europe
13.2.4.5.2.1.Market Estimation, 2015 – 2022
13.2.4.5.2.2.Market Forecast, 2023 – 2031
13.2.4.5.3.Asia Pacific
13.2.4.5.3.1.Market Estimation, 2015 – 2022
13.2.4.5.3.2.Market Forecast, 2023 – 2031
13.2.4.5.4.Middle East and Africa
13.2.4.5.4.1.Market Estimation, 2015 – 2022
13.2.4.5.4.2.Market Forecast, 2023 – 2031
13.2.4.5.5.Latin America
13.2.4.5.5.1.Market Estimation, 2015 – 2022
13.2.4.5.5.2.Market Forecast, 2023 – 2031
13.3.Key Segment for Channeling Investments
13.3.1.By End Users
14.North America Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
14.1.Overview
14.1.1.North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
14.2.North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
14.2.1.Products
14.2.1.1.TMS Coils
14.2.1.2.Stimulators
14.2.2.Software
14.2.3.Services
14.2.3.1.Software Update
14.2.3.2.Technical Support
14.2.3.3.Others
14.2.4.Accessories
14.2.4.1.Trolley
14.2.4.2.Control Cable
14.2.4.3.HV Cable
14.2.4.4.Others
14.3.North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
14.3.1.Single-pulse
14.3.2.Paired Pulse
14.3.3.Repetitive TMS (rTMS)
14.3.4.Deep Transcranial Magnetic Stimulation (dTMS)
14.4.North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1.Psychiatric Treatments
14.4.1.1.Major Depressive Disorder
14.4.1.2.Obsessive Compulsive Disorder
14.4.1.3.Bipolar Disorder
14.4.1.4.Post-Traumatic Stress Disorder
14.4.1.5.Schizophrenia
14.4.1.6.Smoking Cessation
14.4.2.Neurological Treatments
14.4.2.1.Alzheimer’s Disease
14.4.2.2.Autism
14.4.2.3.Chronic Pain
14.4.2.4.Multiple Sclerosis
14.4.2.5.Parkinson’s Disease
14.4.2.6.Post Stroke Rehabilitation
14.4.2.7.Others
14.5.North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
14.5.1.Pediatric
14.5.2.Adults
14.5.3.Geriatric
14.6.North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
14.6.1.Up to 10
14.6.2.Up to 50
14.6.3.Up to 100
14.7.North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
14.7.1.Hospitals and Clinics
14.7.1.1.Small and Start-up Clinic
14.7.1.2.Large and Multi-site Practices
14.7.2.Research Centers
14.7.3.Deep TMS Treatment Centers
14.7.4.Others
14.8.North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Country
14.8.1.U.S
14.8.1.1.U.S Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
14.8.1.1.1.Products
14.8.1.1.1.1.TMS Coils
14.8.1.1.1.2.Stimulators
14.8.1.1.2.Software
14.8.1.1.3.Services
14.8.1.1.3.1.Software Update
14.8.1.1.3.2.Technical Support
14.8.1.1.3.3.Others
14.8.1.1.4.Accessories
14.8.1.1.4.1.Trolley
14.8.1.1.4.2.Control Cable
14.8.1.1.4.3.HV Cable
14.8.1.1.4.4.Others
14.8.1.2.U.S Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
14.8.1.2.1.Single-pulse
14.8.1.2.2.Paired Pulse
14.8.1.2.3.Repetitive TMS (rTMS)
14.8.1.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
14.8.1.3.U.S Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
14.8.1.3.1.Psychiatric Treatments
14.8.1.3.1.1.Major Depressive Disorder
14.8.1.3.1.2.Obsessive Compulsive Disorder
14.8.1.3.1.3.Bipolar Disorder
14.8.1.3.1.4.Post-Traumatic Stress Disorder
14.8.1.3.1.5.Schizophrenia
14.8.1.3.1.6.Smoking Cessation
14.8.1.3.2.Neurological Treatments
14.8.1.3.2.1.Alzheimer’s Disease
14.8.1.3.2.2.Autism
14.8.1.3.2.3.Chronic Pain
14.8.1.3.2.4.Multiple Sclerosis
14.8.1.3.2.5.Parkinson’s Disease
14.8.1.3.2.6.Post Stroke Rehabilitation
14.8.1.3.2.7.Others
14.8.1.4.U.S Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
14.8.1.4.1.Pediatric
14.8.1.4.2.Adults
14.8.1.4.3.Geriatric
14.8.1.5.U.S Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
14.8.1.5.1.Up to 10
14.8.1.5.2.Up to 50
14.8.1.5.3.Up to 100
14.8.1.6.U.S Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
14.8.1.6.1.Hospitals and Clinics
14.8.1.6.1.1.Small and Start-up Clinic
14.8.1.6.1.2.Large and Multi-site Practices
14.8.1.6.2.Research Centers
14.8.1.6.3.Deep TMS Treatment Centers
14.8.1.6.4.Others
14.8.2.Canada
14.8.2.1.Canada Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
14.8.2.1.1.Products
14.8.2.1.1.1.TMS Coils
14.8.2.1.1.2.Stimulators
14.8.2.1.2.Software
14.8.2.1.3.Services
14.8.2.1.3.1.Software Update
14.8.2.1.3.2.Technical Support
14.8.2.1.3.3.Others
14.8.2.1.4.Accessories
14.8.2.1.4.1.Trolley
14.8.2.1.4.2.Control Cable
14.8.2.1.4.3.HV Cable
14.8.2.1.4.4.Others
14.8.2.2.Canada Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
14.8.2.2.1.Single-pulse
14.8.2.2.2.Paired Pulse
14.8.2.2.3.Repetitive TMS (rTMS)
14.8.2.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
14.8.2.3.Canada Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
14.8.2.3.1.Psychiatric Treatments
14.8.2.3.1.1.Major Depressive Disorder
14.8.2.3.1.2.Obsessive Compulsive Disorder
14.8.2.3.1.3.Bipolar Disorder
14.8.2.3.1.4.Post-Traumatic Stress Disorder
14.8.2.3.1.5.Schizophrenia
14.8.2.3.1.6.Smoking Cessation
14.8.2.3.2.Neurological Treatments
14.8.2.3.2.1.Alzheimer’s Disease
14.8.2.3.2.2.Autism
14.8.2.3.2.3.Chronic Pain
14.8.2.3.2.4.Multiple Sclerosis
14.8.2.3.2.5.Parkinson’s Disease
14.8.2.3.2.6.Post Stroke Rehabilitation
14.8.2.3.2.7.Others
14.8.2.4.Canada Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
14.8.2.4.1.Pediatric
14.8.2.4.2.Adults
14.8.2.4.3.Geriatric
14.8.2.5.Canada Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
14.8.2.5.1.Up to 10
14.8.2.5.2.Up to 50
14.8.2.5.3.Up to 100
14.8.2.6.Canada Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
14.8.2.6.1.Hospitals and Clinics
14.8.2.6.1.1.Small and Start-up Clinic
14.8.2.6.1.2.Large and Multi-site Practices
14.8.2.6.2.Research Centers
14.8.2.6.3.Deep TMS Treatment Centers
14.8.2.6.4.Others
14.8.3.Mexico
14.8.3.1.Mexico Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
14.8.3.1.1.Products
14.8.3.1.1.1.TMS Coils
14.8.3.1.1.2.Stimulators
14.8.3.1.2.Software
14.8.3.1.3.Services
14.8.3.1.3.1.Software Update
14.8.3.1.3.2.Technical Support
14.8.3.1.3.3.Others
14.8.3.1.4.Accessories
14.8.3.1.4.1.Trolley
14.8.3.1.4.2.Control Cable
14.8.3.1.4.3.HV Cable
14.8.3.1.4.4.Others
14.8.3.2.Mexico Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
14.8.3.2.1.Single-pulse
14.8.3.2.2.Paired Pulse
14.8.3.2.3.Repetitive TMS (rTMS)
14.8.3.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
14.8.3.3.Mexico Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
14.8.3.3.1.Psychiatric Treatments
14.8.3.3.1.1.Major Depressive Disorder
14.8.3.3.1.2.Obsessive Compulsive Disorder
14.8.3.3.1.3.Bipolar Disorder
14.8.3.3.1.4.Post-Traumatic Stress Disorder
14.8.3.3.1.5.Schizophrenia
14.8.3.3.1.6.Smoking Cessation
14.8.3.3.2.Neurological Treatments
14.8.3.3.2.1.Alzheimer’s Disease
14.8.3.3.2.2.Autism
14.8.3.3.2.3.Chronic Pain
14.8.3.3.2.4.Multiple Sclerosis
14.8.3.3.2.5.Parkinson’s Disease
14.8.3.3.2.6.Post Stroke Rehabilitation
14.8.3.3.2.7.Others
14.8.3.4.Mexico Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
14.8.3.4.1.Pediatric
14.8.3.4.2.Adults
14.8.3.4.3.Geriatric
14.8.3.5.Mexico Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
14.8.3.5.1.Up to 10
14.8.3.5.2.Up to 50
14.8.3.5.3.Up to 100
14.8.3.6.Mexico Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
14.8.3.6.1.Hospitals and Clinics
14.8.3.6.1.1.Small and Start-up Clinic
14.8.3.6.1.2.Large and Multi-site Practices
14.8.3.6.2.Research Centers
14.8.3.6.3.Deep TMS Treatment Centers
14.8.3.6.4.Others
14.8.4.Rest of North America
14.8.4.1.Rest of North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
14.8.4.1.1.Products
14.8.4.1.1.1.TMS Coils
14.8.4.1.1.2.Stimulators
14.8.4.1.2.Software
14.8.4.1.3.Services
14.8.4.1.3.1.Software Update
14.8.4.1.3.2.Technical Support
14.8.4.1.3.3.Others
14.8.4.1.4.Accessories
14.8.4.1.4.1.Trolley
14.8.4.1.4.2.Control Cable
14.8.4.1.4.3.HV Cable
14.8.4.1.4.4.Others
14.8.4.2.Rest of North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
14.8.4.2.1.Single-pulse
14.8.4.2.2.Paired Pulse
14.8.4.2.3.Repetitive TMS (rTMS)
14.8.4.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
14.8.4.3.Rest of North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
14.8.4.3.1.Psychiatric Treatments
14.8.4.3.1.1.Major Depressive Disorder
14.8.4.3.1.2.Obsessive Compulsive Disorder
14.8.4.3.1.3.Bipolar Disorder
14.8.4.3.1.4.Post-Traumatic Stress Disorder
14.8.4.3.1.5.Schizophrenia
14.8.4.3.1.6.Smoking Cessation
14.8.4.3.2.Neurological Treatments
14.8.4.3.2.1.Alzheimer’s Disease
14.8.4.3.2.2.Autism
14.8.4.3.2.3.Chronic Pain
14.8.4.3.2.4.Multiple Sclerosis
14.8.4.3.2.5.Parkinson’s Disease
14.8.4.3.2.6.Post Stroke Rehabilitation
14.8.4.3.2.7.Others
14.8.4.4.Rest of North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
14.8.4.4.1.Pediatric
14.8.4.4.2.Adults
14.8.4.4.3.Geriatric
14.8.4.5.Rest of North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
14.8.4.5.1.Up to 10
14.8.4.5.2.Up to 50
14.8.4.5.3.Up to 100
14.8.4.6.Rest of North America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
14.8.4.6.1.Hospitals and Clinics
14.8.4.6.1.1.Small and Start-up Clinic
14.8.4.6.1.2.Large and Multi-site Practices
14.8.4.6.2.Research Centers
14.8.4.6.3.Deep TMS Treatment Centers
14.8.4.6.4.Others
14.9.Key Segment for Channeling Investments
14.9.1.By Country
14.9.2.By Components
14.9.3.By Type
14.9.4.By Application
14.9.5.By Age Group
14.9.6.By Hz
14.9.7.By End Users
15.Europe Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
15.1.Overview
15.1.1.Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
15.2.Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
15.2.1.Products
15.2.1.1.TMS Coils
15.2.1.2.Stimulators
15.2.2.Software
15.2.3.Services
15.2.3.1.Software Update
15.2.3.2.Technical Support
15.2.3.3.Others
15.2.4.Accessories
15.2.4.1.Trolley
15.2.4.2.Control Cable
15.2.4.3.HV Cable
15.2.4.4.Others
15.3.Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
15.3.1.Single-pulse
15.3.2.Paired Pulse
15.3.3.Repetitive TMS (rTMS)
15.3.4.Deep Transcranial Magnetic Stimulation (dTMS)
15.4.Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1.Psychiatric Treatments
15.4.1.1.Major Depressive Disorder
15.4.1.2.Obsessive Compulsive Disorder
15.4.1.3.Bipolar Disorder
15.4.1.4.Post-Traumatic Stress Disorder
15.4.1.5.Schizophrenia
15.4.1.6.Smoking Cessation
15.4.2.Neurological Treatments
15.4.2.1.Alzheimer’s Disease
15.4.2.2.Autism
15.4.2.3.Chronic Pain
15.4.2.4.Multiple Sclerosis
15.4.2.5.Parkinson’s Disease
15.4.2.6.Post Stroke Rehabilitation
15.4.2.7.Others
15.5.Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
15.5.1.Pediatric
15.5.2.Adults
15.5.3.Geriatric
15.6.Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
15.6.1.Up to 10
15.6.2.Up to 50
15.6.3.Up to 100
15.7.Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
15.7.1.Hospitals and Clinics
15.7.1.1.Small and Start-up Clinic
15.7.1.2.Large and Multi-site Practices
15.7.2.Research Centers
15.7.3.Deep TMS Treatment Centers
15.7.4.Others
15.8.Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Country
15.8.1.France
15.8.1.1.France Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
15.8.1.1.1.Products
15.8.1.1.1.1.TMS Coils
15.8.1.1.1.2.Stimulators
15.8.1.1.2.Software
15.8.1.1.3.Services
15.8.1.1.3.1.Software Update
15.8.1.1.3.2.Technical Support
15.8.1.1.3.3.Others
15.8.1.1.4.Accessories
15.8.1.1.4.1.Trolley
15.8.1.1.4.2.Control Cable
15.8.1.1.4.3.HV Cable
15.8.1.1.4.4.Others
15.8.1.2.France Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
15.8.1.2.1.Single-pulse
15.8.1.2.2.Paired Pulse
15.8.1.2.3.Repetitive TMS (rTMS)
15.8.1.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
15.8.1.3.France Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
15.8.1.3.1.Psychiatric Treatments
15.8.1.3.1.1.Major Depressive Disorder
15.8.1.3.1.2.Obsessive Compulsive Disorder
15.8.1.3.1.3.Bipolar Disorder
15.8.1.3.1.4.Post-Traumatic Stress Disorder
15.8.1.3.1.5.Schizophrenia
15.8.1.3.1.6.Smoking Cessation
15.8.1.3.2.Neurological Treatments
15.8.1.3.2.1.Alzheimer’s Disease
15.8.1.3.2.2.Autism
15.8.1.3.2.3.Chronic Pain
15.8.1.3.2.4.Multiple Sclerosis
15.8.1.3.2.5.Parkinson’s Disease
15.8.1.3.2.6.Post Stroke Rehabilitation
15.8.1.3.2.7.Others
15.8.1.4.France Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.1.4.1.Pediatric
15.8.1.4.2.Adults
15.8.1.4.3.Geriatric
15.8.1.5.France Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
15.8.1.5.1.Up to 10
15.8.1.5.2.Up to 50
15.8.1.5.3.Up to 100
15.8.1.6.France Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
15.8.1.6.1.Hospitals and Clinics
15.8.1.6.1.1.Small and Start-up Clinic
15.8.1.6.1.2.Large and Multi-site Practices
15.8.1.6.2.Research Centers
15.8.1.6.3.Deep TMS Treatment Centers
15.8.1.6.4.Others
15.8.2.The UK
15.8.2.1.The UK Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
15.8.2.1.1.Products
15.8.2.1.1.1.TMS Coils
15.8.2.1.1.2.Stimulators
15.8.2.1.2.Software
15.8.2.1.3.Services
15.8.2.1.3.1.Software Update
15.8.2.1.3.2.Technical Support
15.8.2.1.3.3.Others
15.8.2.1.4.Accessories
15.8.2.1.4.1.Trolley
15.8.2.1.4.2.Control Cable
15.8.2.1.4.3.HV Cable
15.8.2.1.4.4.Others
15.8.2.2.The UK Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
15.8.2.2.1.Single-pulse
15.8.2.2.2.Paired Pulse
15.8.2.2.3.Repetitive TMS (rTMS)
15.8.2.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
15.8.2.3.The UK Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
15.8.2.3.1.Psychiatric Treatments
15.8.2.3.1.1.Major Depressive Disorder
15.8.2.3.1.2.Obsessive Compulsive Disorder
15.8.2.3.1.3.Bipolar Disorder
15.8.2.3.1.4.Post-Traumatic Stress Disorder
15.8.2.3.1.5.Schizophrenia
15.8.2.3.1.6.Smoking Cessation
15.8.2.3.2.Neurological Treatments
15.8.2.3.2.1.Alzheimer’s Disease
15.8.2.3.2.2.Autism
15.8.2.3.2.3.Chronic Pain
15.8.2.3.2.4.Multiple Sclerosis
15.8.2.3.2.5.Parkinson’s Disease
15.8.2.3.2.6.Post Stroke Rehabilitation
15.8.2.3.2.7.Others
15.8.2.4.The UK Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.2.4.1.Pediatric
15.8.2.4.2.Adults
15.8.2.4.3.Geriatric
15.8.2.5.The UK Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
15.8.2.5.1.Up to 10
15.8.2.5.2.Up to 50
15.8.2.5.3.Up to 100
15.8.2.6.The UK Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
15.8.2.6.1.Hospitals and Clinics
15.8.2.6.1.1.Small and Start-up Clinic
15.8.2.6.1.2.Large and Multi-site Practices
15.8.2.6.2.Research Centers
15.8.2.6.3.Deep TMS Treatment Centers
15.8.2.6.4.Others
15.8.3.Spain
15.8.3.1.Spain Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
15.8.3.1.1.Products
15.8.3.1.1.1.TMS Coils
15.8.3.1.1.2.Stimulators
15.8.3.1.2.Software
15.8.3.1.3.Services
15.8.3.1.3.1.Software Update
15.8.3.1.3.2.Technical Support
15.8.3.1.3.3.Others
15.8.3.1.4.Accessories
15.8.3.1.4.1.Trolley
15.8.3.1.4.2.Control Cable
15.8.3.1.4.3.HV Cable
15.8.3.1.4.4.Others
15.8.3.2.Spain Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
15.8.3.2.1.Single-pulse
15.8.3.2.2.Paired Pulse
15.8.3.2.3.Repetitive TMS (rTMS)
15.8.3.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
15.8.3.3.Spain Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
15.8.3.3.1.Psychiatric Treatments
15.8.3.3.1.1.Major Depressive Disorder
15.8.3.3.1.2.Obsessive Compulsive Disorder
15.8.3.3.1.3.Bipolar Disorder
15.8.3.3.1.4.Post-Traumatic Stress Disorder
15.8.3.3.1.5.Schizophrenia
15.8.3.3.1.6.Smoking Cessation
15.8.3.3.2.Neurological Treatments
15.8.3.3.2.1.Alzheimer’s Disease
15.8.3.3.2.2.Autism
15.8.3.3.2.3.Chronic Pain
15.8.3.3.2.4.Multiple Sclerosis
15.8.3.3.2.5.Parkinson’s Disease
15.8.3.3.2.6.Post Stroke Rehabilitation
15.8.3.3.2.7.Others
15.8.3.4.Spain Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.3.4.1.Pediatric
15.8.3.4.2.Adults
15.8.3.4.3.Geriatric
15.8.3.5.Spain Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
15.8.3.5.1.Up to 10
15.8.3.5.2.Up to 50
15.8.3.5.3.Up to 100
15.8.3.6.Spain Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
15.8.3.6.1.Hospitals and Clinics
15.8.3.6.1.1.Small and Start-up Clinic
15.8.3.6.1.2.Large and Multi-site Practices
15.8.3.6.2.Research Centers
15.8.3.6.3.Deep TMS Treatment Centers
15.8.3.6.4.Others
15.8.4.Germany
15.8.4.1.Germany Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
15.8.4.1.1.Products
15.8.4.1.1.1.TMS Coils
15.8.4.1.1.2.Stimulators
15.8.4.1.2.Software
15.8.4.1.3.Services
15.8.4.1.3.1.Software Update
15.8.4.1.3.2.Technical Support
15.8.4.1.3.3.Others
15.8.4.1.4.Accessories
15.8.4.1.4.1.Trolley
15.8.4.1.4.2.Control Cable
15.8.4.1.4.3.HV Cable
15.8.4.1.4.4.Others
15.8.4.2.Germany Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
15.8.4.2.1.Single-pulse
15.8.4.2.2.Paired Pulse
15.8.4.2.3.Repetitive TMS (rTMS)
15.8.4.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
15.8.4.3.Germany Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
15.8.4.3.1.Psychiatric Treatments
15.8.4.3.1.1.Major Depressive Disorder
15.8.4.3.1.2.Obsessive Compulsive Disorder
15.8.4.3.1.3.Bipolar Disorder
15.8.4.3.1.4.Post-Traumatic Stress Disorder
15.8.4.3.1.5.Schizophrenia
15.8.4.3.1.6.Smoking Cessation
15.8.4.3.2.Neurological Treatments
15.8.4.3.2.1.Alzheimer’s Disease
15.8.4.3.2.2.Autism
15.8.4.3.2.3.Chronic Pain
15.8.4.3.2.4.Multiple Sclerosis
15.8.4.3.2.5.Parkinson’s Disease
15.8.4.3.2.6.Post Stroke Rehabilitation
15.8.4.3.2.7.Others
15.8.4.4.Germany Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.4.4.1.Pediatric
15.8.4.4.2.Adults
15.8.4.4.3.Geriatric
15.8.4.5.Germany Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
15.8.4.5.1.Up to 10
15.8.4.5.2.Up to 50
15.8.4.5.3.Up to 100
15.8.4.6.Germany Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
15.8.4.6.1.Hospitals and Clinics
15.8.4.6.1.1.Small and Start-up Clinic
15.8.4.6.1.2.Large and Multi-site Practices
15.8.4.6.2.Research Centers
15.8.4.6.3.Deep TMS Treatment Centers
15.8.4.6.4.Others
15.8.5.Italy
15.8.5.1.Italy Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
15.8.5.1.1.Products
15.8.5.1.1.1.TMS Coils
15.8.5.1.1.2.Stimulators
15.8.5.1.2.Software
15.8.5.1.3.Services
15.8.5.1.3.1.Software Update
15.8.5.1.3.2.Technical Support
15.8.5.1.3.3.Others
15.8.5.1.4.Accessories
15.8.5.1.4.1.Trolley
15.8.5.1.4.2.Control Cable
15.8.5.1.4.3.HV Cable
15.8.5.1.4.4.Others
15.8.5.2.Italy Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
15.8.5.2.1.Single-pulse
15.8.5.2.2.Paired Pulse
15.8.5.2.3.Repetitive TMS (rTMS)
15.8.5.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
15.8.5.3.Italy Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
15.8.5.3.1.Psychiatric Treatments
15.8.5.3.1.1.Major Depressive Disorder
15.8.5.3.1.2.Obsessive Compulsive Disorder
15.8.5.3.1.3.Bipolar Disorder
15.8.5.3.1.4.Post-Traumatic Stress Disorder
15.8.5.3.1.5.Schizophrenia
15.8.5.3.1.6.Smoking Cessation
15.8.5.3.2.Neurological Treatments
15.8.5.3.2.1.Alzheimer’s Disease
15.8.5.3.2.2.Autism
15.8.5.3.2.3.Chronic Pain
15.8.5.3.2.4.Multiple Sclerosis
15.8.5.3.2.5.Parkinson’s Disease
15.8.5.3.2.6.Post Stroke Rehabilitation
15.8.5.3.2.7.Others
15.8.5.4.Italy Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.5.4.1.Pediatric
15.8.5.4.2.Adults
15.8.5.4.3.Geriatric
15.8.5.5.Italy Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
15.8.5.5.1.Up to 10
15.8.5.5.2.Up to 50
15.8.5.5.3.Up to 100
15.8.5.6.Italy Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
15.8.5.6.1.Hospitals and Clinics
15.8.5.6.1.1.Small and Start-up Clinic
15.8.5.6.1.2.Large and Multi-site Practices
15.8.5.6.2.Research Centers
15.8.5.6.3.Deep TMS Treatment Centers
15.8.5.6.4.Others
15.8.6.Nordic Countries
15.8.6.1.Nordic Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
15.8.6.1.1.Products
15.8.6.1.1.1.TMS Coils
15.8.6.1.1.2.Stimulators
15.8.6.1.2.Software
15.8.6.1.3.Services
15.8.6.1.3.1.Software Update
15.8.6.1.3.2.Technical Support
15.8.6.1.3.3.Others
15.8.6.1.4.Accessories
15.8.6.1.4.1.Trolley
15.8.6.1.4.2.Control Cable
15.8.6.1.4.3.HV Cable
15.8.6.1.4.4.Others
15.8.6.2.Nordic Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
15.8.6.2.1.Single-pulse
15.8.6.2.2.Paired Pulse
15.8.6.2.3.Repetitive TMS (rTMS)
15.8.6.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
15.8.6.3.Nordic Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
15.8.6.3.1.Psychiatric Treatments
15.8.6.3.1.1.Major Depressive Disorder
15.8.6.3.1.2.Obsessive Compulsive Disorder
15.8.6.3.1.3.Bipolar Disorder
15.8.6.3.1.4.Post-Traumatic Stress Disorder
15.8.6.3.1.5.Schizophrenia
15.8.6.3.1.6.Smoking Cessation
15.8.6.3.2.Neurological Treatments
15.8.6.3.2.1.Alzheimer’s Disease
15.8.6.3.2.2.Autism
15.8.6.3.2.3.Chronic Pain
15.8.6.3.2.4.Multiple Sclerosis
15.8.6.3.2.5.Parkinson’s Disease
15.8.6.3.2.6.Post Stroke Rehabilitation
15.8.6.3.2.7.Others
15.8.6.4.Nordic Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.6.4.1.Pediatric
15.8.6.4.2.Adults
15.8.6.4.3.Geriatric
15.8.6.5.Nordic Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
15.8.6.5.1.Up to 10
15.8.6.5.2.Up to 50
15.8.6.5.3.Up to 100
15.8.6.6.Nordic Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
15.8.6.6.1.Hospitals and Clinics
15.8.6.6.1.1.Small and Start-up Clinic
15.8.6.6.1.2.Large and Multi-site Practices
15.8.6.6.2.Research Centers
15.8.6.6.3.Deep TMS Treatment Centers
15.8.6.6.4.Others
15.8.6.7.Nordic Countries Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Country
15.8.6.7.1.Denmark
15.8.6.7.2.Finland
15.8.6.7.3.Iceland
15.8.6.7.4.Sweden
15.8.6.7.5.Norway
15.8.7.Benelux Union
15.8.7.1.Benelux Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
15.8.7.1.1.Products
15.8.7.1.1.1.TMS Coils
15.8.7.1.1.2.Stimulators
15.8.7.1.2.Software
15.8.7.1.3.Services
15.8.7.1.3.1.Software Update
15.8.7.1.3.2.Technical Support
15.8.7.1.3.3.Others
15.8.7.1.4.Accessories
15.8.7.1.4.1.Trolley
15.8.7.1.4.2.Control Cable
15.8.7.1.4.3.HV Cable
15.8.7.1.4.4.Others
15.8.7.2.Benelux Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
15.8.7.2.1.Single-pulse
15.8.7.2.2.Paired Pulse
15.8.7.2.3.Repetitive TMS (rTMS)
15.8.7.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
15.8.7.3.Benelux Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
15.8.7.3.1.Psychiatric Treatments
15.8.7.3.1.1.Major Depressive Disorder
15.8.7.3.1.2.Obsessive Compulsive Disorder
15.8.7.3.1.3.Bipolar Disorder
15.8.7.3.1.4.Post-Traumatic Stress Disorder
15.8.7.3.1.5.Schizophrenia
15.8.7.3.1.6.Smoking Cessation
15.8.7.3.2.Neurological Treatments
15.8.7.3.2.1.Alzheimer’s Disease
15.8.7.3.2.2.Autism
15.8.7.3.2.3.Chronic Pain
15.8.7.3.2.4.Multiple Sclerosis
15.8.7.3.2.5.Parkinson’s Disease
15.8.7.3.2.6.Post Stroke Rehabilitation
15.8.7.3.2.7.Others
15.8.7.4.Benelux Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.7.4.1.Pediatric
15.8.7.4.2.Adults
15.8.7.4.3.Geriatric
15.8.7.5.Benelux Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
15.8.7.5.1.Up to 10
15.8.7.5.2.Up to 50
15.8.7.5.3.Up to 100
15.8.7.6.Benelux Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
15.8.7.6.1.Hospitals and Clinics
15.8.7.6.1.1.Small and Start-up Clinic
15.8.7.6.1.2.Large and Multi-site Practices
15.8.7.6.2.Research Centers
15.8.7.6.3.Deep TMS Treatment Centers
15.8.7.6.4.Others
15.8.7.7.Benelux Union Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Country
15.8.7.7.1.Belgium
15.8.7.7.2.The Netherlands
15.8.7.7.3.Luxembourg
15.8.8.Rest of Europe
15.8.8.1.Rest of Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
15.8.8.1.1.Products
15.8.8.1.1.1.TMS Coils
15.8.8.1.1.2.Stimulators
15.8.8.1.2.Software
15.8.8.1.3.Services
15.8.8.1.3.1.Software Update
15.8.8.1.3.2.Technical Support
15.8.8.1.3.3.Others
15.8.8.1.4.Accessories
15.8.8.1.4.1.Trolley
15.8.8.1.4.2.Control Cable
15.8.8.1.4.3.HV Cable
15.8.8.1.4.4.Others
15.8.8.2.Rest of Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
15.8.8.2.1.Single-pulse
15.8.8.2.2.Paired Pulse
15.8.8.2.3.Repetitive TMS (rTMS)
15.8.8.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
15.8.8.3.Rest of Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
15.8.8.3.1.Psychiatric Treatments
15.8.8.3.1.1.Major Depressive Disorder
15.8.8.3.1.2.Obsessive Compulsive Disorder
15.8.8.3.1.3.Bipolar Disorder
15.8.8.3.1.4.Post-Traumatic Stress Disorder
15.8.8.3.1.5.Schizophrenia
15.8.8.3.1.6.Smoking Cessation
15.8.8.3.2.Neurological Treatments
15.8.8.3.2.1.Alzheimer’s Disease
15.8.8.3.2.2.Autism
15.8.8.3.2.3.Chronic Pain
15.8.8.3.2.4.Multiple Sclerosis
15.8.8.3.2.5.Parkinson’s Disease
15.8.8.3.2.6.Post Stroke Rehabilitation
15.8.8.3.2.7.Others
15.8.8.4.Rest of Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
15.8.8.4.1.Pediatric
15.8.8.4.2.Adults
15.8.8.4.3.Geriatric
15.8.8.5.Rest of Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
15.8.8.5.1.Up to 10
15.8.8.5.2.Up to 50
15.8.8.5.3.Up to 100
15.8.8.6.Rest of Europe Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
15.8.8.6.1.Hospitals and Clinics
15.8.8.6.1.1.Small and Start-up Clinic
15.8.8.6.1.2.Large and Multi-site Practices
15.8.8.6.2.Research Centers
15.8.8.6.3.Deep TMS Treatment Centers
15.8.8.6.4.Others
15.9.Key Segment for Channeling Investments
15.9.1.By Country
15.9.2.By Components
15.9.3.By Type
15.9.4.By Application
15.9.5.By Age Group
15.9.6.By Hz
15.9.7.By End Users
16.Asia Pacific Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
16.1.Overview
16.1.1.Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
16.2.Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
16.2.1.Products
16.2.1.1.TMS Coils
16.2.1.2.Stimulators
16.2.2.Software
16.2.3.Services
16.2.3.1.Software Update
16.2.3.2.Technical Support
16.2.3.3.Others
16.2.4.Accessories
16.2.4.1.Trolley
16.2.4.2.Control Cable
16.2.4.3.HV Cable
16.2.4.4.Others
16.3.Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
16.3.1.Single-pulse
16.3.2.Paired Pulse
16.3.3.Repetitive TMS (rTMS)
16.3.4.Deep Transcranial Magnetic Stimulation (dTMS)
16.4.Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
16.4.1.Psychiatric Treatments
16.4.1.1.Major Depressive Disorder
16.4.1.2.Obsessive Compulsive Disorder
16.4.1.3.Bipolar Disorder
16.4.1.4.Post-Traumatic Stress Disorder
16.4.1.5.Schizophrenia
16.4.1.6.Smoking Cessation
16.4.2.Neurological Treatments
16.4.2.1.Alzheimer’s Disease
16.4.2.2.Autism
16.4.2.3.Chronic Pain
16.4.2.4.Multiple Sclerosis
16.4.2.5.Parkinson’s Disease
16.4.2.6.Post Stroke Rehabilitation
16.4.2.7.Others
16.5.Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
16.5.1.Pediatric
16.5.2.Adults
16.5.3.Geriatric
16.6.Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
16.6.1.Up to 10
16.6.2.Up to 50
16.6.3.Up to 100
16.7.Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
16.7.1.Hospitals and Clinics
16.7.1.1.Small and Start-up Clinic
16.7.1.2.Large and Multi-site Practices
16.7.2.Research Centers
16.7.3.Deep TMS Treatment Centers
16.7.4.Others
16.8.Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Country
16.8.1.China
16.8.1.1.China Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
16.8.1.1.1.Products
16.8.1.1.1.1.TMS Coils
16.8.1.1.1.2.Stimulators
16.8.1.1.2.Software
16.8.1.1.3.Services
16.8.1.1.3.1.Software Update
16.8.1.1.3.2.Technical Support
16.8.1.1.3.3.Others
16.8.1.1.4.Accessories
16.8.1.1.4.1.Trolley
16.8.1.1.4.2.Control Cable
16.8.1.1.4.3.HV Cable
16.8.1.1.4.4.Others
16.8.1.2.China Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
16.8.1.2.1.Single-pulse
16.8.1.2.2.Paired Pulse
16.8.1.2.3.Repetitive TMS (rTMS)
16.8.1.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
16.8.1.3.China Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
16.8.1.3.1.Psychiatric Treatments
16.8.1.3.1.1.Major Depressive Disorder
16.8.1.3.1.2.Obsessive Compulsive Disorder
16.8.1.3.1.3.Bipolar Disorder
16.8.1.3.1.4.Post-Traumatic Stress Disorder
16.8.1.3.1.5.Schizophrenia
16.8.1.3.1.6.Smoking Cessation
16.8.1.3.2.Neurological Treatments
16.8.1.3.2.1.Alzheimer’s Disease
16.8.1.3.2.2.Autism
16.8.1.3.2.3.Chronic Pain
16.8.1.3.2.4.Multiple Sclerosis
16.8.1.3.2.5.Parkinson’s Disease
16.8.1.3.2.6.Post Stroke Rehabilitation
16.8.1.3.2.7.Others
16.8.1.4.China Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.1.4.1.Pediatric
16.8.1.4.2.Adults
16.8.1.4.3.Geriatric
16.8.1.5.China Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
16.8.1.5.1.Up to 10
16.8.1.5.2.Up to 50
16.8.1.5.3.Up to 100
16.8.1.6.China Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
16.8.1.6.1.Hospitals and Clinics
16.8.1.6.1.1.Small and Start-up Clinic
16.8.1.6.1.2.Large and Multi-site Practices
16.8.1.6.2.Research Centers
16.8.1.6.3.Deep TMS Treatment Centers
16.8.1.6.4.Others
16.8.2.Japan
16.8.2.1.Japan Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
16.8.2.1.1.Products
16.8.2.1.1.1.TMS Coils
16.8.2.1.1.2.Stimulators
16.8.2.1.2.Software
16.8.2.1.3.Services
16.8.2.1.3.1.Software Update
16.8.2.1.3.2.Technical Support
16.8.2.1.3.3.Others
16.8.2.1.4.Accessories
16.8.2.1.4.1.Trolley
16.8.2.1.4.2.Control Cable
16.8.2.1.4.3.HV Cable
16.8.2.1.4.4.Others
16.8.2.2.Japan Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
16.8.2.2.1.Single-pulse
16.8.2.2.2.Paired Pulse
16.8.2.2.3.Repetitive TMS (rTMS)
16.8.2.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
16.8.2.3.Japan Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
16.8.2.3.1.Psychiatric Treatments
16.8.2.3.1.1.Major Depressive Disorder
16.8.2.3.1.2.Obsessive Compulsive Disorder
16.8.2.3.1.3.Bipolar Disorder
16.8.2.3.1.4.Post-Traumatic Stress Disorder
16.8.2.3.1.5.Schizophrenia
16.8.2.3.1.6.Smoking Cessation
16.8.2.3.2.Neurological Treatments
16.8.2.3.2.1.Alzheimer’s Disease
16.8.2.3.2.2.Autism
16.8.2.3.2.3.Chronic Pain
16.8.2.3.2.4.Multiple Sclerosis
16.8.2.3.2.5.Parkinson’s Disease
16.8.2.3.2.6.Post Stroke Rehabilitation
16.8.2.3.2.7.Others
16.8.2.4.Japan Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.2.4.1.Pediatric
16.8.2.4.2.Adults
16.8.2.4.3.Geriatric
16.8.2.5.Japan Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
16.8.2.5.1.Up to 10
16.8.2.5.2.Up to 50
16.8.2.5.3.Up to 100
16.8.2.6.Japan Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
16.8.2.6.1.Hospitals and Clinics
16.8.2.6.1.1.Small and Start-up Clinic
16.8.2.6.1.2.Large and Multi-site Practices
16.8.2.6.2.Research Centers
16.8.2.6.3.Deep TMS Treatment Centers
16.8.2.6.4.Others
16.8.3.India
16.8.3.1.India Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
16.8.3.1.1.Products
16.8.3.1.1.1.TMS Coils
16.8.3.1.1.2.Stimulators
16.8.3.1.2.Software
16.8.3.1.3.Services
16.8.3.1.3.1.Software Update
16.8.3.1.3.2.Technical Support
16.8.3.1.3.3.Others
16.8.3.1.4.Accessories
16.8.3.1.4.1.Trolley
16.8.3.1.4.2.Control Cable
16.8.3.1.4.3.HV Cable
16.8.3.1.4.4.Others
16.8.3.2.India Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
16.8.3.2.1.Single-pulse
16.8.3.2.2.Paired Pulse
16.8.3.2.3.Repetitive TMS (rTMS)
16.8.3.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
16.8.3.3.India Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
16.8.3.3.1.Psychiatric Treatments
16.8.3.3.1.1.Major Depressive Disorder
16.8.3.3.1.2.Obsessive Compulsive Disorder
16.8.3.3.1.3.Bipolar Disorder
16.8.3.3.1.4.Post-Traumatic Stress Disorder
16.8.3.3.1.5.Schizophrenia
16.8.3.3.1.6.Smoking Cessation
16.8.3.3.2.Neurological Treatments
16.8.3.3.2.1.Alzheimer’s Disease
16.8.3.3.2.2.Autism
16.8.3.3.2.3.Chronic Pain
16.8.3.3.2.4.Multiple Sclerosis
16.8.3.3.2.5.Parkinson’s Disease
16.8.3.3.2.6.Post Stroke Rehabilitation
16.8.3.3.2.7.Others
16.8.3.4.India Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.3.4.1.Pediatric
16.8.3.4.2.Adults
16.8.3.4.3.Geriatric
16.8.3.5.India Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
16.8.3.5.1.Up to 10
16.8.3.5.2.Up to 50
16.8.3.5.3.Up to 100
16.8.3.6.India Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
16.8.3.6.1.Hospitals and Clinics
16.8.3.6.1.1.Small and Start-up Clinic
16.8.3.6.1.2.Large and Multi-site Practices
16.8.3.6.2.Research Centers
16.8.3.6.3.Deep TMS Treatment Centers
16.8.3.6.4.Others
16.8.4.New Zealand
16.8.4.1.New Zealand Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
16.8.4.1.1.Products
16.8.4.1.1.1.TMS Coils
16.8.4.1.1.2.Stimulators
16.8.4.1.2.Software
16.8.4.1.3.Services
16.8.4.1.3.1.Software Update
16.8.4.1.3.2.Technical Support
16.8.4.1.3.3.Others
16.8.4.1.4.Accessories
16.8.4.1.4.1.Trolley
16.8.4.1.4.2.Control Cable
16.8.4.1.4.3.HV Cable
16.8.4.1.4.4.Others
16.8.4.2.New Zealand Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
16.8.4.2.1.Single-pulse
16.8.4.2.2.Paired Pulse
16.8.4.2.3.Repetitive TMS (rTMS)
16.8.4.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
16.8.4.3.New Zealand Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
16.8.4.3.1.Psychiatric Treatments
16.8.4.3.1.1.Major Depressive Disorder
16.8.4.3.1.2.Obsessive Compulsive Disorder
16.8.4.3.1.3.Bipolar Disorder
16.8.4.3.1.4.Post-Traumatic Stress Disorder
16.8.4.3.1.5.Schizophrenia
16.8.4.3.1.6.Smoking Cessation
16.8.4.3.2.Neurological Treatments
16.8.4.3.2.1.Alzheimer’s Disease
16.8.4.3.2.2.Autism
16.8.4.3.2.3.Chronic Pain
16.8.4.3.2.4.Multiple Sclerosis
16.8.4.3.2.5.Parkinson’s Disease
16.8.4.3.2.6.Post Stroke Rehabilitation
16.8.4.3.2.7.Others
16.8.4.4.New Zealand Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.4.4.1.Pediatric
16.8.4.4.2.Adults
16.8.4.4.3.Geriatric
16.8.4.5.New Zealand Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
16.8.4.5.1.Up to 10
16.8.4.5.2.Up to 50
16.8.4.5.3.Up to 100
16.8.4.6.New Zealand Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
16.8.4.6.1.Hospitals and Clinics
16.8.4.6.1.1.Small and Start-up Clinic
16.8.4.6.1.2.Large and Multi-site Practices
16.8.4.6.2.Research Centers
16.8.4.6.3.Deep TMS Treatment Centers
16.8.4.6.4.Others
16.8.5.Australia
16.8.5.1.Australia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
16.8.5.1.1.Products
16.8.5.1.1.1.TMS Coils
16.8.5.1.1.2.Stimulators
16.8.5.1.2.Software
16.8.5.1.3.Services
16.8.5.1.3.1.Software Update
16.8.5.1.3.2.Technical Support
16.8.5.1.3.3.Others
16.8.5.1.4.Accessories
16.8.5.1.4.1.Trolley
16.8.5.1.4.2.Control Cable
16.8.5.1.4.3.HV Cable
16.8.5.1.4.4.Others
16.8.5.2.Australia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
16.8.5.2.1.Single-pulse
16.8.5.2.2.Paired Pulse
16.8.5.2.3.Repetitive TMS (rTMS)
16.8.5.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
16.8.5.3.Australia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
16.8.5.3.1.Psychiatric Treatments
16.8.5.3.1.1.Major Depressive Disorder
16.8.5.3.1.2.Obsessive Compulsive Disorder
16.8.5.3.1.3.Bipolar Disorder
16.8.5.3.1.4.Post-Traumatic Stress Disorder
16.8.5.3.1.5.Schizophrenia
16.8.5.3.1.6.Smoking Cessation
16.8.5.3.2.Neurological Treatments
16.8.5.3.2.1.Alzheimer’s Disease
16.8.5.3.2.2.Autism
16.8.5.3.2.3.Chronic Pain
16.8.5.3.2.4.Multiple Sclerosis
16.8.5.3.2.5.Parkinson’s Disease
16.8.5.3.2.6.Post Stroke Rehabilitation
16.8.5.3.2.7.Others
16.8.5.4.Australia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.5.4.1.Pediatric
16.8.5.4.2.Adults
16.8.5.4.3.Geriatric
16.8.5.5.Australia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
16.8.5.5.1.Up to 10
16.8.5.5.2.Up to 50
16.8.5.5.3.Up to 100
16.8.5.6.Australia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
16.8.5.6.1.Hospitals and Clinics
16.8.5.6.1.1.Small and Start-up Clinic
16.8.5.6.1.2.Large and Multi-site Practices
16.8.5.6.2.Research Centers
16.8.5.6.3.Deep TMS Treatment Centers
16.8.5.6.4.Others
16.8.6.South Korea
16.8.6.1.South Korea Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
16.8.6.1.1.Products
16.8.6.1.1.1.TMS Coils
16.8.6.1.1.2.Stimulators
16.8.6.1.2.Software
16.8.6.1.3.Services
16.8.6.1.3.1.Software Update
16.8.6.1.3.2.Technical Support
16.8.6.1.3.3.Others
16.8.6.1.4.Accessories
16.8.6.1.4.1.Trolley
16.8.6.1.4.2.Control Cable
16.8.6.1.4.3.HV Cable
16.8.6.1.4.4.Others
16.8.6.2.South Korea Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
16.8.6.2.1.Single-pulse
16.8.6.2.2.Paired Pulse
16.8.6.2.3.Repetitive TMS (rTMS)
16.8.6.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
16.8.6.3.South Korea Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
16.8.6.3.1.Psychiatric Treatments
16.8.6.3.1.1.Major Depressive Disorder
16.8.6.3.1.2.Obsessive Compulsive Disorder
16.8.6.3.1.3.Bipolar Disorder
16.8.6.3.1.4.Post-Traumatic Stress Disorder
16.8.6.3.1.5.Schizophrenia
16.8.6.3.1.6.Smoking Cessation
16.8.6.3.2.Neurological Treatments
16.8.6.3.2.1.Alzheimer’s Disease
16.8.6.3.2.2.Autism
16.8.6.3.2.3.Chronic Pain
16.8.6.3.2.4.Multiple Sclerosis
16.8.6.3.2.5.Parkinson’s Disease
16.8.6.3.2.6.Post Stroke Rehabilitation
16.8.6.3.2.7.Others
16.8.6.4.South Korea Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.6.4.1.Pediatric
16.8.6.4.2.Adults
16.8.6.4.3.Geriatric
16.8.6.5.South Korea Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
16.8.6.5.1.Up to 10
16.8.6.5.2.Up to 50
16.8.6.5.3.Up to 100
16.8.6.6.South Korea Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
16.8.6.6.1.Hospitals and Clinics
16.8.6.6.1.1.Small and Start-up Clinic
16.8.6.6.1.2.Large and Multi-site Practices
16.8.6.6.2.Research Centers
16.8.6.6.3.Deep TMS Treatment Centers
16.8.6.6.4.Others
16.8.7.Southeast Asia
16.8.7.1.Southeast Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
16.8.7.1.1.Products
16.8.7.1.1.1.TMS Coils
16.8.7.1.1.2.Stimulators
16.8.7.1.2.Software
16.8.7.1.3.Services
16.8.7.1.3.1.Software Update
16.8.7.1.3.2.Technical Support
16.8.7.1.3.3.Others
16.8.7.1.4.Accessories
16.8.7.1.4.1.Trolley
16.8.7.1.4.2.Control Cable
16.8.7.1.4.3.HV Cable
16.8.7.1.4.4.Others
16.8.7.2.Southeast Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
16.8.7.2.1.Single-pulse
16.8.7.2.2.Paired Pulse
16.8.7.2.3.Repetitive TMS (rTMS)
16.8.7.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
16.8.7.3.Southeast Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
16.8.7.3.1.Psychiatric Treatments
16.8.7.3.1.1.Major Depressive Disorder
16.8.7.3.1.2.Obsessive Compulsive Disorder
16.8.7.3.1.3.Bipolar Disorder
16.8.7.3.1.4.Post-Traumatic Stress Disorder
16.8.7.3.1.5.Schizophrenia
16.8.7.3.1.6.Smoking Cessation
16.8.7.3.2.Neurological Treatments
16.8.7.3.2.1.Alzheimer’s Disease
16.8.7.3.2.2.Autism
16.8.7.3.2.3.Chronic Pain
16.8.7.3.2.4.Multiple Sclerosis
16.8.7.3.2.5.Parkinson’s Disease
16.8.7.3.2.6.Post Stroke Rehabilitation
16.8.7.3.2.7.Others
16.8.7.4.Southeast Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.7.4.1.Pediatric
16.8.7.4.2.Adults
16.8.7.4.3.Geriatric
16.8.7.5.Southeast Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
16.8.7.5.1.Up to 10
16.8.7.5.2.Up to 50
16.8.7.5.3.Up to 100
16.8.7.6.Southeast Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
16.8.7.6.1.Hospitals and Clinics
16.8.7.6.1.1.Small and Start-up Clinic
16.8.7.6.1.2.Large and Multi-site Practices
16.8.7.6.2.Research Centers
16.8.7.6.3.Deep TMS Treatment Centers
16.8.7.6.4.Others
16.8.7.7.Southeast Asia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Country
16.8.7.7.1.Indonesia
16.8.7.7.2.Thailand
16.8.7.7.3.Malaysia
16.8.7.7.4.Singapore
16.8.7.7.5.Rest of Southeast Asia
16.8.8.Rest of Asia Pacific
16.8.8.1.Rest of Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
16.8.8.1.1.Products
16.8.8.1.1.1.TMS Coils
16.8.8.1.1.2.Stimulators
16.8.8.1.2.Software
16.8.8.1.3.Services
16.8.8.1.3.1.Software Update
16.8.8.1.3.2.Technical Support
16.8.8.1.3.3.Others
16.8.8.1.4.Accessories
16.8.8.1.4.1.Trolley
16.8.8.1.4.2.Control Cable
16.8.8.1.4.3.HV Cable
16.8.8.1.4.4.Others
16.8.8.2.Rest of Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
16.8.8.2.1.Single-pulse
16.8.8.2.2.Paired Pulse
16.8.8.2.3.Repetitive TMS (rTMS)
16.8.8.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
16.8.8.3.Rest of Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
16.8.8.3.1.Psychiatric Treatments
16.8.8.3.1.1.Major Depressive Disorder
16.8.8.3.1.2.Obsessive Compulsive Disorder
16.8.8.3.1.3.Bipolar Disorder
16.8.8.3.1.4.Post-Traumatic Stress Disorder
16.8.8.3.1.5.Schizophrenia
16.8.8.3.1.6.Smoking Cessation
16.8.8.3.2.Neurological Treatments
16.8.8.3.2.1.Alzheimer’s Disease
16.8.8.3.2.2.Autism
16.8.8.3.2.3.Chronic Pain
16.8.8.3.2.4.Multiple Sclerosis
16.8.8.3.2.5.Parkinson’s Disease
16.8.8.3.2.6.Post Stroke Rehabilitation
16.8.8.3.2.7.Others
16.8.8.4.Rest of Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
16.8.8.4.1.Pediatric
16.8.8.4.2.Adults
16.8.8.4.3.Geriatric
16.8.8.5.Rest of Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
16.8.8.5.1.Up to 10
16.8.8.5.2.Up to 50
16.8.8.5.3.Up to 100
16.8.8.6.Rest of Asia Pacific Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
16.8.8.6.1.Hospitals and Clinics
16.8.8.6.1.1.Small and Start-up Clinic
16.8.8.6.1.2.Large and Multi-site Practices
16.8.8.6.2.Research Centers
16.8.8.6.3.Deep TMS Treatment Centers
16.8.8.6.4.Others
16.9.Key Segment for Channeling Investments
16.9.1.By Country
16.9.2.By Components
16.9.3.By Type
16.9.4.By Application
16.9.5.By Age Group
16.9.6.By Hz
16.9.7.By End Users
17.Middle East and Africa Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
17.1.Overview
17.1.1.Middle East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
17.2.Middle East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
17.2.1.Products
17.2.1.1.TMS Coils
17.2.1.2.Stimulators
17.2.2.Software
17.2.3.Services
17.2.3.1.Software Update
17.2.3.2.Technical Support
17.2.3.3.Others
17.2.4.Accessories
17.2.4.1.Trolley
17.2.4.2.Control Cable
17.2.4.3.HV Cable
17.2.4.4.Others
17.3.Middle East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
17.3.1.Single-pulse
17.3.2.Paired Pulse
17.3.3.Repetitive TMS (rTMS)
17.3.4.Deep Transcranial Magnetic Stimulation (dTMS)
17.4.Middle East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
17.4.1.Psychiatric Treatments
17.4.1.1.Major Depressive Disorder
17.4.1.2.Obsessive Compulsive Disorder
17.4.1.3.Bipolar Disorder
17.4.1.4.Post-Traumatic Stress Disorder
17.4.1.5.Schizophrenia
17.4.1.6.Smoking Cessation
17.4.2.Neurological Treatments
17.4.2.1.Alzheimer’s Disease
17.4.2.2.Autism
17.4.2.3.Chronic Pain
17.4.2.4.Multiple Sclerosis
17.4.2.5.Parkinson’s Disease
17.4.2.6.Post Stroke Rehabilitation
17.4.2.7.Others
17.5.Middle East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
17.5.1.Pediatric
17.5.2.Adults
17.5.3.Geriatric
17.6.Middle East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
17.6.1.Up to 10
17.6.2.Up to 50
17.6.3.Up to 100
17.7.Middle East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
17.7.1.Hospitals and Clinics
17.7.1.1.Small and Start-up Clinic
17.7.1.2.Large and Multi-site Practices
17.7.2.Research Centers
17.7.3.Deep TMS Treatment Centers
17.7.4.Others
17.8.Middle East and Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Country
17.8.1.Saudi Arabia
17.8.1.1.Saudi Arabia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
17.8.1.1.1.Products
17.8.1.1.1.1.TMS Coils
17.8.1.1.1.2.Stimulators
17.8.1.1.2.Software
17.8.1.1.3.Services
17.8.1.1.3.1.Software Update
17.8.1.1.3.2.Technical Support
17.8.1.1.3.3.Others
17.8.1.1.4.Accessories
17.8.1.1.4.1.Trolley
17.8.1.1.4.2.Control Cable
17.8.1.1.4.3.HV Cable
17.8.1.1.4.4.Others
17.8.1.2.Saudi Arabia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
17.8.1.2.1.Single-pulse
17.8.1.2.2.Paired Pulse
17.8.1.2.3.Repetitive TMS (rTMS)
17.8.1.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
17.8.1.3.Saudi Arabia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
17.8.1.3.1.Psychiatric Treatments
17.8.1.3.1.1.Major Depressive Disorder
17.8.1.3.1.2.Obsessive Compulsive Disorder
17.8.1.3.1.3.Bipolar Disorder
17.8.1.3.1.4.Post-Traumatic Stress Disorder
17.8.1.3.1.5.Schizophrenia
17.8.1.3.1.6.Smoking Cessation
17.8.1.3.2.Neurological Treatments
17.8.1.3.2.1.Alzheimer’s Disease
17.8.1.3.2.2.Autism
17.8.1.3.2.3.Chronic Pain
17.8.1.3.2.4.Multiple Sclerosis
17.8.1.3.2.5.Parkinson’s Disease
17.8.1.3.2.6.Post Stroke Rehabilitation
17.8.1.3.2.7.Others
17.8.1.4.Saudi Arabia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
17.8.1.4.1.Pediatric
17.8.1.4.2.Adults
17.8.1.4.3.Geriatric
17.8.1.5.Saudi Arabia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
17.8.1.5.1.Up to 10
17.8.1.5.2.Up to 50
17.8.1.5.3.Up to 100
17.8.1.6.Saudi Arabia Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
17.8.1.6.1.Hospitals and Clinics
17.8.1.6.1.1.Small and Start-up Clinic
17.8.1.6.1.2.Large and Multi-site Practices
17.8.1.6.2.Research Centers
17.8.1.6.3.Deep TMS Treatment Centers
17.8.1.6.4.Others
17.8.2.UAE
17.8.2.1.UAE Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
17.8.2.1.1.Products
17.8.2.1.1.1.TMS Coils
17.8.2.1.1.2.Stimulators
17.8.2.1.2.Software
17.8.2.1.3.Services
17.8.2.1.3.1.Software Update
17.8.2.1.3.2.Technical Support
17.8.2.1.3.3.Others
17.8.2.1.4.Accessories
17.8.2.1.4.1.Trolley
17.8.2.1.4.2.Control Cable
17.8.2.1.4.3.HV Cable
17.8.2.1.4.4.Others
17.8.2.2.UAE Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
17.8.2.2.1.Single-pulse
17.8.2.2.2.Paired Pulse
17.8.2.2.3.Repetitive TMS (rTMS)
17.8.2.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
17.8.2.3.UAE Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
17.8.2.3.1.Psychiatric Treatments
17.8.2.3.1.1.Major Depressive Disorder
17.8.2.3.1.2.Obsessive Compulsive Disorder
17.8.2.3.1.3.Bipolar Disorder
17.8.2.3.1.4.Post-Traumatic Stress Disorder
17.8.2.3.1.5.Schizophrenia
17.8.2.3.1.6.Smoking Cessation
17.8.2.3.2.Neurological Treatments
17.8.2.3.2.1.Alzheimer’s Disease
17.8.2.3.2.2.Autism
17.8.2.3.2.3.Chronic Pain
17.8.2.3.2.4.Multiple Sclerosis
17.8.2.3.2.5.Parkinson’s Disease
17.8.2.3.2.6.Post Stroke Rehabilitation
17.8.2.3.2.7.Others
17.8.2.4.UAE Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
17.8.2.4.1.Pediatric
17.8.2.4.2.Adults
17.8.2.4.3.Geriatric
17.8.2.5.UAE Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
17.8.2.5.1.Up to 10
17.8.2.5.2.Up to 50
17.8.2.5.3.Up to 100
17.8.2.6.UAE Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
17.8.2.6.1.Hospitals and Clinics
17.8.2.6.1.1.Small and Start-up Clinic
17.8.2.6.1.2.Large and Multi-site Practices
17.8.2.6.2.Research Centers
17.8.2.6.3.Deep TMS Treatment Centers
17.8.2.6.4.Others
17.8.3.Egypt
17.8.3.1.Egypt Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
17.8.3.1.1.Products
17.8.3.1.1.1.TMS Coils
17.8.3.1.1.2.Stimulators
17.8.3.1.2.Software
17.8.3.1.3.Services
17.8.3.1.3.1.Software Update
17.8.3.1.3.2.Technical Support
17.8.3.1.3.3.Others
17.8.3.1.4.Accessories
17.8.3.1.4.1.Trolley
17.8.3.1.4.2.Control Cable
17.8.3.1.4.3.HV Cable
17.8.3.1.4.4.Others
17.8.3.2.Egypt Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
17.8.3.2.1.Single-pulse
17.8.3.2.2.Paired Pulse
17.8.3.2.3.Repetitive TMS (rTMS)
17.8.3.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
17.8.3.3.Egypt Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
17.8.3.3.1.Psychiatric Treatments
17.8.3.3.1.1.Major Depressive Disorder
17.8.3.3.1.2.Obsessive Compulsive Disorder
17.8.3.3.1.3.Bipolar Disorder
17.8.3.3.1.4.Post-Traumatic Stress Disorder
17.8.3.3.1.5.Schizophrenia
17.8.3.3.1.6.Smoking Cessation
17.8.3.3.2.Neurological Treatments
17.8.3.3.2.1.Alzheimer’s Disease
17.8.3.3.2.2.Autism
17.8.3.3.2.3.Chronic Pain
17.8.3.3.2.4.Multiple Sclerosis
17.8.3.3.2.5.Parkinson’s Disease
17.8.3.3.2.6.Post Stroke Rehabilitation
17.8.3.3.2.7.Others
17.8.3.4.Egypt Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
17.8.3.4.1.Pediatric
17.8.3.4.2.Adults
17.8.3.4.3.Geriatric
17.8.3.5.Egypt Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
17.8.3.5.1.Up to 10
17.8.3.5.2.Up to 50
17.8.3.5.3.Up to 100
17.8.3.6.Egypt Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
17.8.3.6.1.Hospitals and Clinics
17.8.3.6.1.1.Small and Start-up Clinic
17.8.3.6.1.2.Large and Multi-site Practices
17.8.3.6.2.Research Centers
17.8.3.6.3.Deep TMS Treatment Centers
17.8.3.6.4.Others
17.8.4.Kuwait
17.8.4.1.Kuwait Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
17.8.4.1.1.Products
17.8.4.1.1.1.TMS Coils
17.8.4.1.1.2.Stimulators
17.8.4.1.2.Software
17.8.4.1.3.Services
17.8.4.1.3.1.Software Update
17.8.4.1.3.2.Technical Support
17.8.4.1.3.3.Others
17.8.4.1.4.Accessories
17.8.4.1.4.1.Trolley
17.8.4.1.4.2.Control Cable
17.8.4.1.4.3.HV Cable
17.8.4.1.4.4.Others
17.8.4.2.Kuwait Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
17.8.4.2.1.Single-pulse
17.8.4.2.2.Paired Pulse
17.8.4.2.3.Repetitive TMS (rTMS)
17.8.4.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
17.8.4.3.Kuwait Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
17.8.4.3.1.Psychiatric Treatments
17.8.4.3.1.1.Major Depressive Disorder
17.8.4.3.1.2.Obsessive Compulsive Disorder
17.8.4.3.1.3.Bipolar Disorder
17.8.4.3.1.4.Post-Traumatic Stress Disorder
17.8.4.3.1.5.Schizophrenia
17.8.4.3.1.6.Smoking Cessation
17.8.4.3.2.Neurological Treatments
17.8.4.3.2.1.Alzheimer’s Disease
17.8.4.3.2.2.Autism
17.8.4.3.2.3.Chronic Pain
17.8.4.3.2.4.Multiple Sclerosis
17.8.4.3.2.5.Parkinson’s Disease
17.8.4.3.2.6.Post Stroke Rehabilitation
17.8.4.3.2.7.Others
17.8.4.4.Kuwait Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
17.8.4.4.1.Pediatric
17.8.4.4.2.Adults
17.8.4.4.3.Geriatric
17.8.4.5.Kuwait Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
17.8.4.5.1.Up to 10
17.8.4.5.2.Up to 50
17.8.4.5.3.Up to 100
17.8.4.6.Kuwait Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
17.8.4.6.1.Hospitals and Clinics
17.8.4.6.1.1.Small and Start-up Clinic
17.8.4.6.1.2.Large and Multi-site Practices
17.8.4.6.2.Research Centers
17.8.4.6.3.Deep TMS Treatment Centers
17.8.4.6.4.Others
17.8.5.South Africa
17.8.5.1.South Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
17.8.5.1.1.Products
17.8.5.1.1.1.TMS Coils
17.8.5.1.1.2.Stimulators
17.8.5.1.2.Software
17.8.5.1.3.Services
17.8.5.1.3.1.Software Update
17.8.5.1.3.2.Technical Support
17.8.5.1.3.3.Others
17.8.5.1.4.Accessories
17.8.5.1.4.1.Trolley
17.8.5.1.4.2.Control Cable
17.8.5.1.4.3.HV Cable
17.8.5.1.4.4.Others
17.8.5.2.South Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
17.8.5.2.1.Single-pulse
17.8.5.2.2.Paired Pulse
17.8.5.2.3.Repetitive TMS (rTMS)
17.8.5.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
17.8.5.3.South Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
17.8.5.3.1.Psychiatric Treatments
17.8.5.3.1.1.Major Depressive Disorder
17.8.5.3.1.2.Obsessive Compulsive Disorder
17.8.5.3.1.3.Bipolar Disorder
17.8.5.3.1.4.Post-Traumatic Stress Disorder
17.8.5.3.1.5.Schizophrenia
17.8.5.3.1.6.Smoking Cessation
17.8.5.3.2.Neurological Treatments
17.8.5.3.2.1.Alzheimer’s Disease
17.8.5.3.2.2.Autism
17.8.5.3.2.3.Chronic Pain
17.8.5.3.2.4.Multiple Sclerosis
17.8.5.3.2.5.Parkinson’s Disease
17.8.5.3.2.6.Post Stroke Rehabilitation
17.8.5.3.2.7.Others
17.8.5.4.South Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
17.8.5.4.1.Pediatric
17.8.5.4.2.Adults
17.8.5.4.3.Geriatric
17.8.5.5.South Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
17.8.5.5.1.Up to 10
17.8.5.5.2.Up to 50
17.8.5.5.3.Up to 100
17.8.5.6.South Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
17.8.5.6.1.Hospitals and Clinics
17.8.5.6.1.1.Small and Start-up Clinic
17.8.5.6.1.2.Large and Multi-site Practices
17.8.5.6.2.Research Centers
17.8.5.6.3.Deep TMS Treatment Centers
17.8.5.6.4.Others
17.8.6.Rest of Middle East & Africa
17.8.6.1.Rest of Middle East & Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
17.8.6.1.1.Products
17.8.6.1.1.1.TMS Coils
17.8.6.1.1.2.Stimulators
17.8.6.1.2.Software
17.8.6.1.3.Services
17.8.6.1.3.1.Software Update
17.8.6.1.3.2.Technical Support
17.8.6.1.3.3.Others
17.8.6.1.4.Accessories
17.8.6.1.4.1.Trolley
17.8.6.1.4.2.Control Cable
17.8.6.1.4.3.HV Cable
17.8.6.1.4.4.Others
17.8.6.2.Rest of Middle East & Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
17.8.6.2.1.Single-pulse
17.8.6.2.2.Paired Pulse
17.8.6.2.3.Repetitive TMS (rTMS)
17.8.6.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
17.8.6.3.Rest of Middle East & Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
17.8.6.3.1.Psychiatric Treatments
17.8.6.3.1.1.Major Depressive Disorder
17.8.6.3.1.2.Obsessive Compulsive Disorder
17.8.6.3.1.3.Bipolar Disorder
17.8.6.3.1.4.Post-Traumatic Stress Disorder
17.8.6.3.1.5.Schizophrenia
17.8.6.3.1.6.Smoking Cessation
17.8.6.3.2.Neurological Treatments
17.8.6.3.2.1.Alzheimer’s Disease
17.8.6.3.2.2.Autism
17.8.6.3.2.3.Chronic Pain
17.8.6.3.2.4.Multiple Sclerosis
17.8.6.3.2.5.Parkinson’s Disease
17.8.6.3.2.6.Post Stroke Rehabilitation
17.8.6.3.2.7.Others
17.8.6.4.Rest of Middle East & Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
17.8.6.4.1.Pediatric
17.8.6.4.2.Adults
17.8.6.4.3.Geriatric
17.8.6.5.Rest of Middle East & Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
17.8.6.5.1.Up to 10
17.8.6.5.2.Up to 50
17.8.6.5.3.Up to 100
17.8.6.6.Rest of Middle East & Africa Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
17.8.6.6.1.Hospitals and Clinics
17.8.6.6.1.1.Small and Start-up Clinic
17.8.6.6.1.2.Large and Multi-site Practices
17.8.6.6.2.Research Centers
17.8.6.6.3.Deep TMS Treatment Centers
17.8.6.6.4.Others
17.9.Key Segment for Channeling Investments
17.9.1.By Country
17.9.2.By Components
17.9.3.By Type
17.9.4.By Application
17.9.5.By Age Group
17.9.6.By Hz
17.9.7.By End Users
18.Latin America Transcranial Magnetic Stimulator Market Analysis and Forecasts, 2023 – 2031
18.1.Overview
18.1.1.Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn)
18.2.Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
18.2.1.Products
18.2.1.1.TMS Coils
18.2.1.2.Stimulators
18.2.2.Software
18.2.3.Services
18.2.3.1.Software Update
18.2.3.2.Technical Support
18.2.3.3.Others
18.2.4.Accessories
18.2.4.1.Trolley
18.2.4.2.Control Cable
18.2.4.3.HV Cable
18.2.4.4.Others
18.3.Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
18.3.1.Single-pulse
18.3.2.Paired Pulse
18.3.3.Repetitive TMS (rTMS)
18.3.4.Deep Transcranial Magnetic Stimulation (dTMS)
18.4.Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
18.4.1.Psychiatric Treatments
18.4.1.1.Major Depressive Disorder
18.4.1.2.Obsessive Compulsive Disorder
18.4.1.3.Bipolar Disorder
18.4.1.4.Post-Traumatic Stress Disorder
18.4.1.5.Schizophrenia
18.4.1.6.Smoking Cessation
18.4.2.Neurological Treatments
18.4.2.1.Alzheimer’s Disease
18.4.2.2.Autism
18.4.2.3.Chronic Pain
18.4.2.4.Multiple Sclerosis
18.4.2.5.Parkinson’s Disease
18.4.2.6.Post Stroke Rehabilitation
18.4.2.7.Others
18.5.Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
18.5.1.Pediatric
18.5.2.Adults
18.5.3.Geriatric
18.6.Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
18.6.1.Up to 10
18.6.2.Up to 50
18.6.3.Up to 100
18.7.Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
18.7.1.Hospitals and Clinics
18.7.1.1.Small and Start-up Clinic
18.7.1.2.Large and Multi-site Practices
18.7.2.Research Centers
18.7.3.Deep TMS Treatment Centers
18.7.4.Others
18.8.Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Country
18.8.1.Brazil
18.8.1.1.Brazil Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
18.8.1.1.1.Products
18.8.1.1.1.1.TMS Coils
18.8.1.1.1.2.Stimulators
18.8.1.1.2.Software
18.8.1.1.3.Services
18.8.1.1.3.1.Software Update
18.8.1.1.3.2.Technical Support
18.8.1.1.3.3.Others
18.8.1.1.4.Accessories
18.8.1.1.4.1.Trolley
18.8.1.1.4.2.Control Cable
18.8.1.1.4.3.HV Cable
18.8.1.1.4.4.Others
18.8.1.2.Brazil Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
18.8.1.2.1.Single-pulse
18.8.1.2.2.Paired Pulse
18.8.1.2.3.Repetitive TMS (rTMS)
18.8.1.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
18.8.1.3.Brazil Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
18.8.1.3.1.Psychiatric Treatments
18.8.1.3.1.1.Major Depressive Disorder
18.8.1.3.1.2.Obsessive Compulsive Disorder
18.8.1.3.1.3.Bipolar Disorder
18.8.1.3.1.4.Post-Traumatic Stress Disorder
18.8.1.3.1.5.Schizophrenia
18.8.1.3.1.6.Smoking Cessation
18.8.1.3.2.Neurological Treatments
18.8.1.3.2.1.Alzheimer’s Disease
18.8.1.3.2.2.Autism
18.8.1.3.2.3.Chronic Pain
18.8.1.3.2.4.Multiple Sclerosis
18.8.1.3.2.5.Parkinson’s Disease
18.8.1.3.2.6.Post Stroke Rehabilitation
18.8.1.3.2.7.Others
18.8.1.4.Brazil Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
18.8.1.4.1.Pediatric
18.8.1.4.2.Adults
18.8.1.4.3.Geriatric
18.8.1.5.Brazil Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
18.8.1.5.1.Up to 10
18.8.1.5.2.Up to 50
18.8.1.5.3.Up to 100
18.8.1.6.Brazil Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
18.8.1.6.1.Hospitals and Clinics
18.8.1.6.1.1.Small and Start-up Clinic
18.8.1.6.1.2.Large and Multi-site Practices
18.8.1.6.2.Research Centers
18.8.1.6.3.Deep TMS Treatment Centers
18.8.1.6.4.Others
18.8.2.Argentina
18.8.2.1.Argentina Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
18.8.2.1.1.Products
18.8.2.1.1.1.TMS Coils
18.8.2.1.1.2.Stimulators
18.8.2.1.2.Software
18.8.2.1.3.Services
18.8.2.1.3.1.Software Update
18.8.2.1.3.2.Technical Support
18.8.2.1.3.3.Others
18.8.2.1.4.Accessories
18.8.2.1.4.1.Trolley
18.8.2.1.4.2.Control Cable
18.8.2.1.4.3.HV Cable
18.8.2.1.4.4.Others
18.8.2.2.Argentina Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
18.8.2.2.1.Single-pulse
18.8.2.2.2.Paired Pulse
18.8.2.2.3.Repetitive TMS (rTMS)
18.8.2.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
18.8.2.3.Argentina Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
18.8.2.3.1.Psychiatric Treatments
18.8.2.3.1.1.Major Depressive Disorder
18.8.2.3.1.2.Obsessive Compulsive Disorder
18.8.2.3.1.3.Bipolar Disorder
18.8.2.3.1.4.Post-Traumatic Stress Disorder
18.8.2.3.1.5.Schizophrenia
18.8.2.3.1.6.Smoking Cessation
18.8.2.3.2.Neurological Treatments
18.8.2.3.2.1.Alzheimer’s Disease
18.8.2.3.2.2.Autism
18.8.2.3.2.3.Chronic Pain
18.8.2.3.2.4.Multiple Sclerosis
18.8.2.3.2.5.Parkinson’s Disease
18.8.2.3.2.6.Post Stroke Rehabilitation
18.8.2.3.2.7.Others
18.8.2.4.Argentina Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
18.8.2.4.1.Pediatric
18.8.2.4.2.Adults
18.8.2.4.3.Geriatric
18.8.2.5.Argentina Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
18.8.2.5.1.Up to 10
18.8.2.5.2.Up to 50
18.8.2.5.3.Up to 100
18.8.2.6.Argentina Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
18.8.2.6.1.Hospitals and Clinics
18.8.2.6.1.1.Small and Start-up Clinic
18.8.2.6.1.2.Large and Multi-site Practices
18.8.2.6.2.Research Centers
18.8.2.6.3.Deep TMS Treatment Centers
18.8.2.6.4.Others
18.8.3.Rest of Latin America
18.8.3.1.Rest of Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Components
18.8.3.1.1.Products
18.8.3.1.1.1.TMS Coils
18.8.3.1.1.2.Stimulators
18.8.3.1.2.Software
18.8.3.1.3.Services
18.8.3.1.3.1.Software Update
18.8.3.1.3.2.Technical Support
18.8.3.1.3.3.Others
18.8.3.1.4.Accessories
18.8.3.1.4.1.Trolley
18.8.3.1.4.2.Control Cable
18.8.3.1.4.3.HV Cable
18.8.3.1.4.4.Others
18.8.3.2.Rest of Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Type
18.8.3.2.1.Single-pulse
18.8.3.2.2.Paired Pulse
18.8.3.2.3.Repetitive TMS (rTMS)
18.8.3.2.4.Deep Transcranial Magnetic Stimulation (dTMS)
18.8.3.3.Rest of Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Application
18.8.3.3.1.Psychiatric Treatments
18.8.3.3.1.1.Major Depressive Disorder
18.8.3.3.1.2.Obsessive Compulsive Disorder
18.8.3.3.1.3.Bipolar Disorder
18.8.3.3.1.4.Post-Traumatic Stress Disorder
18.8.3.3.1.5.Schizophrenia
18.8.3.3.1.6.Smoking Cessation
18.8.3.3.2.Neurological Treatments
18.8.3.3.2.1.Alzheimer’s Disease
18.8.3.3.2.2.Autism
18.8.3.3.2.3.Chronic Pain
18.8.3.3.2.4.Multiple Sclerosis
18.8.3.3.2.5.Parkinson’s Disease
18.8.3.3.2.6.Post Stroke Rehabilitation
18.8.3.3.2.7.Others
18.8.3.4.Rest of Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Age Group
18.8.3.4.1.Pediatric
18.8.3.4.2.Adults
18.8.3.4.3.Geriatric
18.8.3.5.Rest of Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By Hz
18.8.3.5.1.Up to 10
18.8.3.5.2.Up to 50
18.8.3.5.3.Up to 100
18.8.3.6.Rest of Latin America Transcranial Magnetic Stimulator Market Revenue (US$ Mn) and Forecasts, By End Users
18.8.3.6.1.Hospitals and Clinics
18.8.3.6.1.1.Small and Start-up Clinic
18.8.3.6.1.2.Large and Multi-site Practices
18.8.3.6.2.Research Centers
18.8.3.6.3.Deep TMS Treatment Centers
18.8.3.6.4.Others
18.9.Key Segment for Channeling Investments
18.9.1.By Country
18.9.2.By Components
18.9.3.By Type
18.9.4.By Application
18.9.5.By Age Group
18.9.6.By Hz
18.9.7.By End Users
19.Competitive Benchmarking
19.1.Brand Benchmarking
19.2.Market Share Analysis, 2022
19.3.Global Presence and Growth Strategies
19.3.1.Mergers and Acquisitions
19.3.2.Product Launches
19.3.3.Investments Trends
19.3.4.R&D Initiatives
20.Player Profiles
20.1.BrainsWay
20.1.1.Company Details
20.1.2.Company Overview
20.1.3.Product Offerings
20.1.4.Key Developments
20.1.5.Financial Analysis
20.1.6.SWOT Analysis
20.1.7.Business Strategies
20.2.eNeura Inc.
20.2.1.Company Details
20.2.2.Company Overview
20.2.3.Product Offerings
20.2.4.Key Developments
20.2.5.Financial Analysis
20.2.6.SWOT Analysis
20.2.7.Business Strategies
20.3.Magnus Medical
20.3.1.Company Details
20.3.2.Company Overview
20.3.3.Product Offerings
20.3.4.Key Developments
20.3.5.Financial Analysis
20.3.6.SWOT Analysis
20.3.7.Business Strategies
20.4.Magstim
20.4.1.Company Details
20.4.2.Company Overview
20.4.3.Product Offerings
20.4.4.Key Developments
20.4.5.Financial Analysis
20.4.6.SWOT Analysis
20.4.7.Business Strategies
20.5.MagVenture, Inc.
20.5.1.Company Details
20.5.2.Company Overview
20.5.3.Product Offerings
20.5.4.Key Developments
20.5.5.Financial Analysis
20.5.6.SWOT Analysis
20.5.7.Business Strategies
20.6.Neuronetics
20.6.1.Company Details
20.6.2.Company Overview
20.6.3.Product Offerings
20.6.4.Key Developments
20.6.5.Financial Analysis
20.6.6.SWOT Analysis
20.6.7.Business Strategies
20.7.Neurosoft
20.7.1.Company Details
20.7.2.Company Overview
20.7.3.Product Offerings
20.7.4.Key Developments
20.7.5.Financial Analysis
20.7.6.SWOT Analysis
20.7.7.Business Strategies
20.8.Nexstim, Inc.
20.8.1.Company Details
20.8.2.Company Overview
20.8.3.Product Offerings
20.8.4.Key Developments
20.8.5.Financial Analysis
20.8.6.SWOT Analysis
20.8.7.Business Strategies
20.9.Sebers Medical
20.9.1.Company Details
20.9.2.Company Overview
20.9.3.Product Offerings
20.9.4.Key Developments
20.9.5.Financial Analysis
20.9.6.SWOT Analysis
20.9.7.Business Strategies
20.10.Other Market Participants
21.Key Findings

.

**Exclusive for Multi-User and Enterprise User.

Global Transcranial Magnetic Stimulator MarketSegmentation

By Components

 Products
· TMS Coils
· Stimulators
 Software
 Services
· Software Update
· Technical Support
· Others
 Accessories
· Trolley
· Control Cable
· HV Cable
· Others

By Type

 Single-pulse
 Paired Pulse
 Repetitive TMS (rTMS)
 Deep Transcranial Magnetic Stimulation (dTMS)

By Application

 Psychiatric Treatments
· Major Depressive Disorder
· Obsessive Compulsive Disorder
· Bipolar Disorder
· Post-Traumatic Stress Disorder
· Schizophrenia
· Smoking Cessation
 Neurological Treatments
· Alzheimer’s Disease
· Autism
· Chronic Pain
· Multiple Sclerosis
· Parkinson’s Disease
· Post Stroke Rehabilitation
· Others

By Age Group

 Pediatric
 Adults
 Geriatric

By Hz

 Up to 10
 Up to 50
 Up to 100

By End Users

 Hospitals and Clinics
· Small and Start-up Clinic
· Large and Multi-site Practices
 Research Centers
 Deep TMS Treatment Centers
 Others

By Region

 North America (U.S., Canada, Mexico, Rest of North America)
 Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
 Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
 Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
 Latin America (Brazil, Argentina, Rest of Latin America)

**Note: The report covers cross-segmentation analysis by region further into countries

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.

 

 

Procure Comprehensive Study of

Global Transcranial Magnetic Stimulator Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top